JP2005519878A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519878A5 JP2005519878A5 JP2003546881A JP2003546881A JP2005519878A5 JP 2005519878 A5 JP2005519878 A5 JP 2005519878A5 JP 2003546881 A JP2003546881 A JP 2003546881A JP 2003546881 A JP2003546881 A JP 2003546881A JP 2005519878 A5 JP2005519878 A5 JP 2005519878A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrazol
- hydrazono
- ylamine
- pyrazole
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 264
- 125000003118 aryl group Chemical group 0.000 claims description 212
- 125000001424 substituent group Chemical group 0.000 claims description 140
- 125000005843 halogen group Chemical group 0.000 claims description 137
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims description 124
- 125000001188 haloalkyl group Chemical group 0.000 claims description 111
- 125000000623 heterocyclic group Chemical group 0.000 claims description 101
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 68
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 57
- -1 3-methoxy-5-trifluoromethylphenyl Chemical group 0.000 claims description 55
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 17
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 15
- 125000004076 pyridyl group Chemical group 0.000 claims description 11
- 125000003386 piperidinyl group Chemical group 0.000 claims description 10
- 125000002757 morpholinyl group Chemical group 0.000 claims description 9
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 8
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 claims description 7
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 6
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 6
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 6
- 125000004193 piperazinyl group Chemical group 0.000 claims description 5
- 125000000335 thiazolyl group Chemical group 0.000 claims description 5
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 claims description 4
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 4
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 4
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 3
- 125000002541 furyl group Chemical group 0.000 claims description 3
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 3
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 193
- 239000001257 hydrogen Substances 0.000 claims 193
- 150000001875 compounds Chemical class 0.000 claims 160
- 150000002431 hydrogen Chemical class 0.000 claims 126
- 125000003710 aryl alkyl group Chemical group 0.000 claims 116
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 67
- 239000008194 pharmaceutical composition Substances 0.000 claims 61
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 49
- 125000002947 alkylene group Chemical group 0.000 claims 48
- 125000003545 alkoxy group Chemical group 0.000 claims 40
- 239000000203 mixture Substances 0.000 claims 36
- 239000000546 pharmaceutical excipient Substances 0.000 claims 30
- 239000003085 diluting agent Substances 0.000 claims 29
- 239000003937 drug carrier Substances 0.000 claims 29
- 150000003839 salts Chemical class 0.000 claims 20
- 125000004995 haloalkylthio group Chemical group 0.000 claims 18
- 125000005164 aryl thioalkyl group Chemical group 0.000 claims 15
- 239000012453 solvate Substances 0.000 claims 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 13
- 125000006517 heterocyclyl carbonyl group Chemical group 0.000 claims 11
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 10
- 230000003463 hyperproliferative effect Effects 0.000 claims 10
- 125000003342 alkenyl group Chemical group 0.000 claims 9
- 125000000753 cycloalkyl group Chemical group 0.000 claims 9
- AKQZEFRALAUBFS-UHFFFAOYSA-N ilamine Natural products COC(C)C(O)(C(=O)OCC1=CCN2CCCC12)C(C)(C)O AKQZEFRALAUBFS-UHFFFAOYSA-N 0.000 claims 9
- 201000010099 disease Diseases 0.000 claims 8
- 125000004450 alkenylene group Chemical group 0.000 claims 7
- 125000004414 alkyl thio group Chemical group 0.000 claims 6
- 230000033115 angiogenesis Effects 0.000 claims 5
- 208000035475 disorder Diseases 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 5
- TZPCPCOGYXZHMH-UHFFFAOYSA-N (4e)-4-(phenylhydrazinylidene)-5-pyridin-3-ylpyrazol-3-amine Chemical compound NC1=NN=C(C=2C=NC=CC=2)C1=NNC1=CC=CC=C1 TZPCPCOGYXZHMH-UHFFFAOYSA-N 0.000 claims 4
- PRFCJSJLZZUTMW-UHFFFAOYSA-N (4e)-4-(phenylhydrazinylidene)-5-pyridin-4-ylpyrazol-3-amine Chemical compound NC1=NN=C(C=2C=CN=CC=2)C1=NNC1=CC=CC=C1 PRFCJSJLZZUTMW-UHFFFAOYSA-N 0.000 claims 4
- FFTPRBGYDRYEPQ-UHFFFAOYSA-N (4e)-4-[(3,4-difluorophenyl)hydrazinylidene]-5-pyridin-3-ylpyrazol-3-amine Chemical compound NC1=NN=C(C=2C=NC=CC=2)C1=NNC1=CC=C(F)C(F)=C1 FFTPRBGYDRYEPQ-UHFFFAOYSA-N 0.000 claims 4
- MEJLRQLLZPMRLF-UHFFFAOYSA-N (4e)-4-[(3-fluoro-4-methoxyphenyl)hydrazinylidene]-5-pyridin-4-ylpyrazol-3-amine Chemical compound C1=C(F)C(OC)=CC=C1NN=C1C(C=2C=CN=CC=2)=NN=C1N MEJLRQLLZPMRLF-UHFFFAOYSA-N 0.000 claims 4
- RJQGSADMYLSRSH-UHFFFAOYSA-N (4e)-4-[(3-fluorophenyl)hydrazinylidene]-5-(3-methylphenyl)pyrazol-3-amine Chemical compound CC1=CC=CC(C=2C(C(N)=NN=2)=NNC=2C=C(F)C=CC=2)=C1 RJQGSADMYLSRSH-UHFFFAOYSA-N 0.000 claims 4
- CTYKHPMLHJVKHX-UHFFFAOYSA-N (4e)-4-[(3-fluorophenyl)hydrazinylidene]-5-(4-methoxyphenyl)pyrazol-3-amine Chemical compound C1=CC(OC)=CC=C1C1=NN=C(N)C1=NNC1=CC=CC(F)=C1 CTYKHPMLHJVKHX-UHFFFAOYSA-N 0.000 claims 4
- BLWZYZFDMGHETD-UHFFFAOYSA-N (4e)-4-[(3-fluorophenyl)hydrazinylidene]-5-(4-methylphenyl)pyrazol-3-amine Chemical compound C1=CC(C)=CC=C1C1=NN=C(N)C1=NNC1=CC=CC(F)=C1 BLWZYZFDMGHETD-UHFFFAOYSA-N 0.000 claims 4
- JSENNZWOEPJIPS-UHFFFAOYSA-N (4e)-4-[(3-fluorophenyl)hydrazinylidene]-5-[3-(trifluoromethyl)phenyl]pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C(C=CC=2)C(F)(F)F)C1=NNC1=CC=CC(F)=C1 JSENNZWOEPJIPS-UHFFFAOYSA-N 0.000 claims 4
- IWCGBBQUCCAVGA-UHFFFAOYSA-N (4e)-4-[(3-fluorophenyl)hydrazinylidene]-5-[4-(trifluoromethoxy)phenyl]pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=CC(OC(F)(F)F)=CC=2)C1=NNC1=CC=CC(F)=C1 IWCGBBQUCCAVGA-UHFFFAOYSA-N 0.000 claims 4
- VVBFKBYTQJBTPB-UHFFFAOYSA-N (4e)-4-[(3-fluorophenyl)hydrazinylidene]-5-pyridin-4-ylpyrazol-3-amine Chemical compound NC1=NN=C(C=2C=CN=CC=2)C1=NNC1=CC=CC(F)=C1 VVBFKBYTQJBTPB-UHFFFAOYSA-N 0.000 claims 4
- MFXHPOJRBWDBBP-UHFFFAOYSA-N (4e)-5-(3-chlorophenyl)-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C(Cl)C=CC=2)C1=NNC1=CC=CC(F)=C1 MFXHPOJRBWDBBP-UHFFFAOYSA-N 0.000 claims 4
- MSTYMZUSMKYHJL-UHFFFAOYSA-N (4e)-5-(4-chlorophenyl)-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=CC(Cl)=CC=2)C1=NNC1=CC=CC(F)=C1 MSTYMZUSMKYHJL-UHFFFAOYSA-N 0.000 claims 4
- OUKNLVQNIFYFDZ-UHFFFAOYSA-N (4e)-5-(furan-2-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2OC=CC=2)\C1=N\NC1=CC=CC=C1 OUKNLVQNIFYFDZ-UHFFFAOYSA-N 0.000 claims 4
- QLNDTNYYPMNYCP-UHFFFAOYSA-N 2-[3-[(2e)-2-(3-amino-5-pyridin-4-ylpyrazol-4-ylidene)hydrazinyl]phenyl]sulfonylethanol Chemical compound NC1=NN=C(C=2C=CN=CC=2)C1=NNC1=CC=CC(S(=O)(=O)CCO)=C1 QLNDTNYYPMNYCP-UHFFFAOYSA-N 0.000 claims 4
- UDGCBOJAGBIKAE-UHFFFAOYSA-N 3-[2-(3-amino-5-morpholin-4-ylpyrazol-4-ylidene)hydrazinyl]benzenesulfonamide Chemical compound C=1C=CC(S(N)(=O)=O)=CC=1NN=C1C(N)=NN=C1N1CCOCC1 UDGCBOJAGBIKAE-UHFFFAOYSA-N 0.000 claims 4
- LBAPEKNSFCQQPK-UHFFFAOYSA-N 4-(phenylhydrazinylidene)-5-thiophen-3-ylpyrazol-3-amine Chemical compound NC1=NN=C(C2=CSC=C2)C1=NNC1=CC=CC=C1 LBAPEKNSFCQQPK-UHFFFAOYSA-N 0.000 claims 4
- VXVMOKZIUFRCLT-UHFFFAOYSA-N 4-[(3-fluoro-4-methoxyphenyl)hydrazinylidene]pyrazol-3-amine Chemical compound C1=C(F)C(OC)=CC=C1NN=C1C(N)=NN=C1 VXVMOKZIUFRCLT-UHFFFAOYSA-N 0.000 claims 4
- VMFBFJXRWNIGBQ-UHFFFAOYSA-N 4-[(3-fluorophenyl)hydrazinylidene]-5-(furan-2-yl)pyrazol-3-amine Chemical compound NC1=NN=C(C=2OC=CC=2)C1=NNC1=CC=CC(F)=C1 VMFBFJXRWNIGBQ-UHFFFAOYSA-N 0.000 claims 4
- YCCNOGZZWLCVPN-UHFFFAOYSA-N 4-[(3-fluorophenyl)hydrazinylidene]-5-(morpholin-4-ylmethyl)pyrazol-3-amine Chemical compound C=1C=CC(F)=CC=1NN=C1C(N)=NN=C1CN1CCOCC1 YCCNOGZZWLCVPN-UHFFFAOYSA-N 0.000 claims 4
- VFMJZFJEDNQJJN-UHFFFAOYSA-N 4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-amine Chemical compound NC1=NN=CC1=NNC1=CC=CC(F)=C1 VFMJZFJEDNQJJN-UHFFFAOYSA-N 0.000 claims 4
- LEVYJSOULZVOQU-UHFFFAOYSA-N 4-[[3-(morpholin-4-ylmethyl)phenyl]hydrazinylidene]-5-pyridin-4-ylpyrazol-3-amine Chemical compound NC1=NN=C(C=2C=CN=CC=2)C1=NNC(C=1)=CC=CC=1CN1CCOCC1 LEVYJSOULZVOQU-UHFFFAOYSA-N 0.000 claims 4
- KVHNGYMZTQXLOZ-UHFFFAOYSA-N 4-[[4-fluoro-3-(trifluoromethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(F)C(C(F)(F)F)=C1 KVHNGYMZTQXLOZ-UHFFFAOYSA-N 0.000 claims 4
- JNLYBOGJWDTFMR-UHFFFAOYSA-N 5-(3-nitrophenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C(C=CC=2)[N+]([O-])=O)C1=NNC1=CC=CC=C1 JNLYBOGJWDTFMR-UHFFFAOYSA-N 0.000 claims 4
- RCBOHFIBUYSRBK-UHFFFAOYSA-N 5-(4-nitrophenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=CC(=CC=2)[N+]([O-])=O)C1=NNC1=CC=CC=C1 RCBOHFIBUYSRBK-UHFFFAOYSA-N 0.000 claims 4
- NFYORNMHVKCDFC-UHFFFAOYSA-N 5-methyl-4-[(3-nitrophenyl)diazenyl]-1H-pyrazol-3-amine Chemical compound NC1=C(C(=NN1)C)N=NC1=CC(=CC=C1)[N+](=O)[O-] NFYORNMHVKCDFC-UHFFFAOYSA-N 0.000 claims 4
- 206010061218 Inflammation Diseases 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 230000004054 inflammatory process Effects 0.000 claims 4
- CCHHAHOTQJKUNT-UHFFFAOYSA-N n-[(3-amino-5-but-3-enylpyrazol-4-ylidene)amino]pyridin-3-amine Chemical compound NC1=NN=C(CCC=C)C1=NNC1=CC=CN=C1 CCHHAHOTQJKUNT-UHFFFAOYSA-N 0.000 claims 4
- WOQXKYAYBQWQCG-UHFFFAOYSA-N n-[(3-amino-5-methylpyrazol-4-ylidene)amino]isoquinolin-5-amine Chemical compound CC1=NN=C(N)C1=NNC1=CC=CC2=CN=CC=C12 WOQXKYAYBQWQCG-UHFFFAOYSA-N 0.000 claims 4
- GQLHFSCTSCWIRR-UHFFFAOYSA-N n-[(3-amino-5-methylpyrazol-4-ylidene)amino]phthalazin-5-amine Chemical compound CC1=NN=C(N)C1=NNC1=CC=CC2=CN=NC=C12 GQLHFSCTSCWIRR-UHFFFAOYSA-N 0.000 claims 4
- IFIWAXWPHZTQAL-UHFFFAOYSA-N n-[(e)-(3-amino-5-pyridin-4-ylpyrazol-4-ylidene)amino]isoquinolin-5-amine Chemical compound C=1C=CC2=CN=CC=C2C=1NN=C1C(N)=NN=C1C1=CC=NC=C1 IFIWAXWPHZTQAL-UHFFFAOYSA-N 0.000 claims 4
- ZBHCUEQBXAPHAA-UHFFFAOYSA-N n-[(e)-[3-amino-5-[(4-methoxyphenyl)methyl]pyrazol-4-ylidene]amino]pyridin-3-amine Chemical compound C1=CC(OC)=CC=C1CC1=NN=C(N)C1=NNC1=CC=CN=C1 ZBHCUEQBXAPHAA-UHFFFAOYSA-N 0.000 claims 4
- BKGMBCUNSUZOGU-UHFFFAOYSA-N n-[[(4z)-5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methyl]-2-chloro-6-methylpyridine-3-carboxamide Chemical compound ClC1=NC(C)=CC=C1C(=O)NCC1=NN=C(N)C1=NNC1=CC=CC(F)=C1 BKGMBCUNSUZOGU-UHFFFAOYSA-N 0.000 claims 4
- 125000003884 phenylalkyl group Chemical group 0.000 claims 4
- 206010029113 Neovascularisation Diseases 0.000 claims 3
- INSWERQZXYQHHB-UHFFFAOYSA-N n-[(e)-(3-amino-5-pyridin-4-ylpyrazol-4-ylidene)amino]pyridin-3-amine Chemical compound NC1=NN=C(C=2C=CN=CC=2)C1=NNC1=CC=CN=C1 INSWERQZXYQHHB-UHFFFAOYSA-N 0.000 claims 3
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 3
- IFGLKCAHWDTUSU-UHFFFAOYSA-N (3,5-diamino-4-phenyldiazenylpyrazol-1-yl)-phenylmethanone Chemical compound NC1=C(N=NC=2C=CC=CC=2)C(N)=NN1C(=O)C1=CC=CC=C1 IFGLKCAHWDTUSU-UHFFFAOYSA-N 0.000 claims 2
- YDBNPZSBUNZAOA-UHFFFAOYSA-N (4e)-4-(phenylhydrazinylidene)-5-(3,4,5-trimethoxyphenyl)pyrazol-3-amine Chemical compound COC1=C(OC)C(OC)=CC(C=2C(C(N)=NN=2)=NNC=2C=CC=CC=2)=C1 YDBNPZSBUNZAOA-UHFFFAOYSA-N 0.000 claims 2
- JFTGDOYWQZQAKJ-UHFFFAOYSA-N (4e)-4-(phenylhydrazinylidene)-5-[2-(1,2,4-triazol-1-yl)propan-2-yl]pyrazol-3-amine Chemical compound C1=NC=NN1C(C)(C)C1=NN=C(N)C1=NNC1=CC=CC=C1 JFTGDOYWQZQAKJ-UHFFFAOYSA-N 0.000 claims 2
- QJUMCCRSNZGICL-UHFFFAOYSA-N (4e)-4-(phenylhydrazinylidene)-5-[2-(trifluoromethoxy)phenyl]pyrazol-3-amine Chemical compound NC1=NN=C(C=2C(=CC=CC=2)OC(F)(F)F)C1=NNC1=CC=CC=C1 QJUMCCRSNZGICL-UHFFFAOYSA-N 0.000 claims 2
- KQIRTQLHKZNPFZ-UHFFFAOYSA-N (4e)-4-(phenylhydrazinylidene)-5-[4-(trifluoromethyl)phenyl]pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=CC(=CC=2)C(F)(F)F)C1=NNC1=CC=CC=C1 KQIRTQLHKZNPFZ-UHFFFAOYSA-N 0.000 claims 2
- YVMZJHWAYVGCDJ-UHFFFAOYSA-N (4e)-4-(phenylhydrazinylidene)-5-[4-(trifluoromethylsulfanyl)phenyl]pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=CC(SC(F)(F)F)=CC=2)C1=NNC1=CC=CC=C1 YVMZJHWAYVGCDJ-UHFFFAOYSA-N 0.000 claims 2
- ZZMXYYFUWQSFEW-UHFFFAOYSA-N (4e)-4-(phenylhydrazinylidene)-5-thiophen-2-ylpyrazol-3-amine Chemical compound NC1=NN=C(C=2SC=CC=2)\C1=N\NC1=CC=CC=C1 ZZMXYYFUWQSFEW-UHFFFAOYSA-N 0.000 claims 2
- SUDNIPQPLNFBEW-UHFFFAOYSA-N (4e)-4-[(3,4-difluorophenyl)hydrazinylidene]-5-[(2-morpholin-4-ylethylamino)methyl]pyrazol-3-amine Chemical compound C=1C=C(F)C(F)=CC=1NN=C1C(N)=NN=C1CNCCN1CCOCC1 SUDNIPQPLNFBEW-UHFFFAOYSA-N 0.000 claims 2
- UZDHFBYJCWAOSA-UHFFFAOYSA-N (4e)-4-[(3,4-difluorophenyl)hydrazinylidene]-5-pyridin-4-ylpyrazol-3-amine Chemical compound NC1=NN=C(C=2C=CN=CC=2)C1=NNC1=CC=C(F)C(F)=C1 UZDHFBYJCWAOSA-UHFFFAOYSA-N 0.000 claims 2
- QYXKURQTXGOGPS-UHFFFAOYSA-N (4e)-4-[(3,4-difluorophenyl)hydrazinylidene]-n-ethyl-5-methylpyrazol-3-amine Chemical compound CCNC1=NN=C(C)\C1=N/NC1=CC=C(F)C(F)=C1 QYXKURQTXGOGPS-UHFFFAOYSA-N 0.000 claims 2
- VSRJENFZFZKAJS-UHFFFAOYSA-N (4e)-4-[(3,4-difluorophenyl)hydrazinylidene]-n-methyl-5-pyridin-4-ylpyrazol-3-amine Chemical compound CNC1=NN=C(C=2C=CN=CC=2)C1=NNC1=CC=C(F)C(F)=C1 VSRJENFZFZKAJS-UHFFFAOYSA-N 0.000 claims 2
- ILGBBXVCGYONHF-UHFFFAOYSA-N (4e)-4-[(3,5-difluorophenyl)hydrazinylidene]-5-(2-phenylethyl)pyrazol-3-amine Chemical compound C=1C(F)=CC(F)=CC=1NN=C1C(N)=NN=C1CCC1=CC=CC=C1 ILGBBXVCGYONHF-UHFFFAOYSA-N 0.000 claims 2
- MJUKGZPWBMTPDL-UHFFFAOYSA-N (4e)-4-[(3-chlorophenyl)hydrazinylidene]-5-(2-phenylethyl)pyrazol-3-amine Chemical compound C=1C=CC(Cl)=CC=1NN=C1C(N)=NN=C1CCC1=CC=CC=C1 MJUKGZPWBMTPDL-UHFFFAOYSA-N 0.000 claims 2
- JTNRMZCRNQNDDV-UHFFFAOYSA-N (4e)-4-[(3-fluorophenyl)hydrazinylidene]-5-(2-methylfuran-3-yl)pyrazol-3-amine Chemical compound O1C=CC(C=2C(C(N)=NN=2)=NNC=2C=C(F)C=CC=2)=C1C JTNRMZCRNQNDDV-UHFFFAOYSA-N 0.000 claims 2
- HBYITLHIDBVVIE-UHFFFAOYSA-N (4e)-4-[(3-fluorophenyl)hydrazinylidene]-5-(2-phenylethyl)pyrazol-3-amine Chemical compound C=1C=CC(F)=CC=1NN=C1C(N)=NN=C1CCC1=CC=CC=C1 HBYITLHIDBVVIE-UHFFFAOYSA-N 0.000 claims 2
- KPAWZHBZOUPWOJ-UHFFFAOYSA-N (4e)-4-[(3-fluorophenyl)hydrazinylidene]-5-n,5-n-dimethylpyrazole-3,5-diamine Chemical compound CN(C)C1=NN=C(N)C1=NNC1=CC=CC(F)=C1 KPAWZHBZOUPWOJ-UHFFFAOYSA-N 0.000 claims 2
- WJDWIJFTYTUPCS-UHFFFAOYSA-N (4e)-4-[(6-chloropyridin-3-yl)hydrazinylidene]-5-n,5-n-dimethylpyrazole-3,5-diamine Chemical compound CN(C)C1=NN=C(N)C1=NNC1=CC=C(Cl)N=C1 WJDWIJFTYTUPCS-UHFFFAOYSA-N 0.000 claims 2
- LAYBPTPWKYGAOP-UHFFFAOYSA-N (4e)-4-[(6-fluoropyridin-3-yl)hydrazinylidene]-5-n,5-n-dimethylpyrazole-3,5-diamine Chemical compound CN(C)C1=NN=C(N)C1=NNC1=CC=C(F)N=C1 LAYBPTPWKYGAOP-UHFFFAOYSA-N 0.000 claims 2
- OZINSXJBLUBVGA-UHFFFAOYSA-N (4e)-5-(2,5-dimethylfuran-3-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound O1C(C)=CC(C=2C(C(N)=NN=2)=NNC=2C=CC=CC=2)=C1C OZINSXJBLUBVGA-UHFFFAOYSA-N 0.000 claims 2
- YGIADHDYZCAGCJ-UHFFFAOYSA-N (4e)-5-(2-chloro-6-methylpyridin-4-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound ClC1=NC(C)=CC(C=2C(C(N)=NN=2)=NNC=2C=CC=CC=2)=C1 YGIADHDYZCAGCJ-UHFFFAOYSA-N 0.000 claims 2
- ZPEOSHYDLAYPLW-UHFFFAOYSA-N (4e)-5-(3-fluoro-4-methylphenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C1=C(F)C(C)=CC=C1C1=NN=C(N)C1=NNC1=CC=CC=C1 ZPEOSHYDLAYPLW-UHFFFAOYSA-N 0.000 claims 2
- ZTQFOYSYQJROBY-UHFFFAOYSA-N (4e)-5-(4-chloro-3-nitrophenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C(C(Cl)=CC=2)[N+]([O-])=O)C1=NNC1=CC=CC=C1 ZTQFOYSYQJROBY-UHFFFAOYSA-N 0.000 claims 2
- VTAOTWNTJNRLFD-UHFFFAOYSA-N (4e)-5-(4-fluoro-3-methylphenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C1=C(F)C(C)=CC(C=2C(C(N)=NN=2)=NNC=2C=CC=CC=2)=C1 VTAOTWNTJNRLFD-UHFFFAOYSA-N 0.000 claims 2
- AVOVQBASOARMBG-UHFFFAOYSA-N (4e)-5-(4-methylthiadiazol-5-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound N1=NSC(C=2C(C(N)=NN=2)=NNC=2C=CC=CC=2)=C1C AVOVQBASOARMBG-UHFFFAOYSA-N 0.000 claims 2
- XWFZUCJHHFCIMK-UHFFFAOYSA-N (4e)-5-(5-methyl-3-phenyl-1,2-oxazol-4-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C1=NN=C(N)C1=NNC1=CC=CC=C1 XWFZUCJHHFCIMK-UHFFFAOYSA-N 0.000 claims 2
- GQYKYEDGUIXFGO-UHFFFAOYSA-N (4e)-5-[(2,5-dimethoxyphenyl)methyl]-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound COC1=CC=C(OC)C(CC=2C(C(N)=NN=2)=NNC=2C=CC=CC=2)=C1 GQYKYEDGUIXFGO-UHFFFAOYSA-N 0.000 claims 2
- PZGLDZIXCJYYFR-UHFFFAOYSA-N (4e)-5-[(2-nitrophenoxy)methyl]-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C=1C=CC=CC=1NN=C1C(N)=NN=C1COC1=CC=CC=C1[N+]([O-])=O PZGLDZIXCJYYFR-UHFFFAOYSA-N 0.000 claims 2
- RHWBTQICPVAUBG-UHFFFAOYSA-N (4e)-5-[(3,4-dimethoxyphenyl)methyl]-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NN=C(N)C1=NNC1=CC=CC=C1 RHWBTQICPVAUBG-UHFFFAOYSA-N 0.000 claims 2
- QXTQLQNFIGATOA-UHFFFAOYSA-N (4e)-5-[(3-ethylphenyl)methyl]-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound CCC1=CC=CC(CC=2C(C(N)=NN=2)=NNC=2C=CC=CC=2)=C1 QXTQLQNFIGATOA-UHFFFAOYSA-N 0.000 claims 2
- GBKCVEYCQNFMQO-UHFFFAOYSA-N (4e)-5-[(4-chlorophenoxy)methyl]-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C=1C=CC=CC=1NN=C1C(N)=NN=C1COC1=CC=C(Cl)C=C1 GBKCVEYCQNFMQO-UHFFFAOYSA-N 0.000 claims 2
- TVKZJBZHQAVLBO-UHFFFAOYSA-N (4e)-5-[(4-chlorophenyl)methyl]-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C=1C=CC=CC=1NN=C1C(N)=NN=C1CC1=CC=C(Cl)C=C1 TVKZJBZHQAVLBO-UHFFFAOYSA-N 0.000 claims 2
- KTDQFQDYXNANBS-UHFFFAOYSA-N (4e)-5-[5-(4-chlorophenyl)-2-methylfuran-3-yl]-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound CC=1OC(C=2C=CC(Cl)=CC=2)=CC=1C1=NN=C(N)C1=NNC1=CC=CC=C1 KTDQFQDYXNANBS-UHFFFAOYSA-N 0.000 claims 2
- NYVBSUZMDDLGAM-UHFFFAOYSA-N (4e)-5-[5-methyl-2-(trifluoromethyl)furan-3-yl]-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound O1C(C)=CC(C=2C(C(N)=NN=2)=NNC=2C=CC=CC=2)=C1C(F)(F)F NYVBSUZMDDLGAM-UHFFFAOYSA-N 0.000 claims 2
- CAIMRQJIDMQSQA-UHFFFAOYSA-N (4e)-5-[[bis(2-morpholin-4-ylethyl)amino]methyl]-4-[(3,4-difluorophenyl)hydrazinylidene]pyrazol-3-amine Chemical compound C=1C=C(F)C(F)=CC=1NN=C1C(N)=NN=C1CN(CCN1CCOCC1)CCN1CCOCC1 CAIMRQJIDMQSQA-UHFFFAOYSA-N 0.000 claims 2
- NMTUUINPFLYHGN-UHFFFAOYSA-N (4e)-5-but-3-enyl-4-[(3,4-difluorophenyl)hydrazinylidene]pyrazol-3-amine Chemical compound NC1=NN=C(CCC=C)C1=NNC1=CC=C(F)C(F)=C1 NMTUUINPFLYHGN-UHFFFAOYSA-N 0.000 claims 2
- DUJKBGDSCQUOAM-UHFFFAOYSA-N (4e)-5-n,5-n-dimethyl-4-(phthalazin-5-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound CN(C)C1=NN=C(N)C1=NNC1=CC=CC2=CN=NC=C12 DUJKBGDSCQUOAM-UHFFFAOYSA-N 0.000 claims 2
- ULZQIURMWLEDQV-UHFFFAOYSA-N (4e)-5-n,5-n-dimethyl-4-(pyridin-3-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound CN(C)C1=NN=C(N)C1=NNC1=CC=CN=C1 ULZQIURMWLEDQV-UHFFFAOYSA-N 0.000 claims 2
- XMRJANUSZMWCGH-UHFFFAOYSA-N (4e)-5-n,5-n-dimethyl-4-(quinolin-6-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound CN(C)C1=NN=C(N)C1=NNC1=CC=C(N=CC=C2)C2=C1 XMRJANUSZMWCGH-UHFFFAOYSA-N 0.000 claims 2
- AAUNXEUQZZAQGT-UHFFFAOYSA-N (4e)-5-n,5-n-dimethyl-4-[[3-(morpholin-4-ylmethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound CN(C)C1=NN=C(N)C1=NNC1=CC=CC(CN2CCOCC2)=C1 AAUNXEUQZZAQGT-UHFFFAOYSA-N 0.000 claims 2
- GBQCLQKRJCEAJM-UHFFFAOYSA-N (4e)-5-tert-butyl-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-amine Chemical compound CC(C)(C)C1=NN=C(N)C1=NNC1=CC=CC(F)=C1 GBQCLQKRJCEAJM-UHFFFAOYSA-N 0.000 claims 2
- DPIPLMSIQDRZOB-UHFFFAOYSA-N (4z)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=CC1=NNC1=CC=CC=C1 DPIPLMSIQDRZOB-UHFFFAOYSA-N 0.000 claims 2
- PROOHIIQOMJJOW-UHFFFAOYSA-N (4z)-4-[(3-fluoro-4-methoxyphenyl)hydrazinylidene]-5-morpholin-4-ylpyrazol-3-amine Chemical compound C1=C(F)C(OC)=CC=C1NN=C1C(N2CCOCC2)=NN=C1N PROOHIIQOMJJOW-UHFFFAOYSA-N 0.000 claims 2
- ZKDOCIWZCZFECB-UHFFFAOYSA-N (4z)-4-[(3-fluorophenyl)hydrazinylidene]-5-morpholin-4-ylpyrazol-3-amine Chemical compound C=1C=CC(F)=CC=1NN=C1C(N)=NN=C1N1CCOCC1 ZKDOCIWZCZFECB-UHFFFAOYSA-N 0.000 claims 2
- MSCULCOBVCVJQH-UHFFFAOYSA-N (4z)-4-[(3-fluorophenyl)hydrazinylidene]-5-pyrrolidin-1-ylpyrazol-3-amine Chemical compound C=1C=CC(F)=CC=1NN=C1C(N)=NN=C1N1CCCC1 MSCULCOBVCVJQH-UHFFFAOYSA-N 0.000 claims 2
- RANTYAOATOSTGC-UHFFFAOYSA-N (4z)-4-[[3-(morpholin-4-ylmethyl)phenyl]hydrazinylidene]-5-pyrrolidin-1-ylpyrazol-3-amine Chemical compound C=1C=CC(CN2CCOCC2)=CC=1NN=C1C(N)=NN=C1N1CCCC1 RANTYAOATOSTGC-UHFFFAOYSA-N 0.000 claims 2
- LQAKZUXNMPBESM-UHFFFAOYSA-N (4z)-4-[[3-[(dimethylamino)methyl]phenyl]hydrazinylidene]-5-morpholin-4-ylpyrazol-3-amine Chemical compound CN(C)CC1=CC=CC(NN=C2C(=NN=C2N)N2CCOCC2)=C1 LQAKZUXNMPBESM-UHFFFAOYSA-N 0.000 claims 2
- FWYUTMHJUBFXKP-UHFFFAOYSA-N (4z)-5-morpholin-4-yl-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C=1C=CC=CC=1NN=C1C(N)=NN=C1N1CCOCC1 FWYUTMHJUBFXKP-UHFFFAOYSA-N 0.000 claims 2
- FNZRIAXTWKACHA-UHFFFAOYSA-N (4z)-5-pyrrolidin-1-yl-4-[[3-(pyrrolidin-1-ylmethyl)phenyl]hydrazinylidene]pyrazol-3-amine Chemical compound C=1C=CC(CN2CCCC2)=CC=1NN=C1C(N)=NN=C1N1CCCC1 FNZRIAXTWKACHA-UHFFFAOYSA-N 0.000 claims 2
- RIXHTDVXZFCKDL-UHFFFAOYSA-N (4z)-5-pyrrolidin-1-yl-4-[[3-(trifluoromethyl)phenyl]hydrazinylidene]pyrazol-3-amine Chemical compound C=1C=CC(C(F)(F)F)=CC=1NN=C1C(N)=NN=C1N1CCCC1 RIXHTDVXZFCKDL-UHFFFAOYSA-N 0.000 claims 2
- BSNLVDJNPAAEPL-UHFFFAOYSA-N 1-(4-bromophenyl)-4-phenyldiazenylpyrazole-3,5-diamine Chemical compound NC1=NN(C=2C=CC(Br)=CC=2)C(N)=C1N=NC1=CC=CC=C1 BSNLVDJNPAAEPL-UHFFFAOYSA-N 0.000 claims 2
- FJFLZSHCDMVTJZ-UHFFFAOYSA-N 1-(4-fluorophenyl)-4-phenyldiazenylpyrazole-3,5-diamine Chemical compound NC1=NN(C=2C=CC(F)=CC=2)C(N)=C1N=NC1=CC=CC=C1 FJFLZSHCDMVTJZ-UHFFFAOYSA-N 0.000 claims 2
- PUUDZOFTOAALGZ-UHFFFAOYSA-N 1-[2-[[5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methylamino]-2-oxoethyl]pyrrolidine-2-carboxylic acid Chemical compound C=1C=CC(F)=CC=1NN=C1C(N)=NN=C1CNC(=O)CN1CCCC1C(O)=O PUUDZOFTOAALGZ-UHFFFAOYSA-N 0.000 claims 2
- DENZGEANZCUSLQ-UHFFFAOYSA-N 1-[3-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]phenyl]ethanethione Chemical compound CC(=S)C1=CC=CC(NN=C2C(=NN=C2N)N)=C1 DENZGEANZCUSLQ-UHFFFAOYSA-N 0.000 claims 2
- XBBUTOFNIPUCSQ-UHFFFAOYSA-N 1-benzyl-4-phenyldiazenylpyrazole-3,5-diamine Chemical compound NC1=C(N=NC=2C=CC=CC=2)C(N)=NN1CC1=CC=CC=C1 XBBUTOFNIPUCSQ-UHFFFAOYSA-N 0.000 claims 2
- ODJMGAMTPSAOJI-UHFFFAOYSA-N 1-methyl-4-phenyldiazenylpyrazole-3,5-diamine Chemical compound CN1N=C(N)C(N=NC=2C=CC=CC=2)=C1N ODJMGAMTPSAOJI-UHFFFAOYSA-N 0.000 claims 2
- ATPMQLROPXAZQD-UHFFFAOYSA-N 2-[3-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]phenyl]sulfonylethanol Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC(S(=O)(=O)CCO)=C1 ATPMQLROPXAZQD-UHFFFAOYSA-N 0.000 claims 2
- VSIAGGSUJFVBTK-UHFFFAOYSA-N 2-[[(4z)-5-amino-4-[(3,4-difluorophenyl)hydrazinylidene]pyrazol-3-yl]methyl]isoindole-1,3-dione Chemical compound NC1=NN=C(CN2C(C3=CC=CC=C3C2=O)=O)C1=NNC1=CC=C(F)C(F)=C1 VSIAGGSUJFVBTK-UHFFFAOYSA-N 0.000 claims 2
- GFXPRGHVUQBRIH-UHFFFAOYSA-N 2-[[5-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]pyridin-2-yl]-(2-hydroxyethyl)amino]ethanol Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(N(CCO)CCO)N=C1 GFXPRGHVUQBRIH-UHFFFAOYSA-N 0.000 claims 2
- MIODETWMLAEHPG-UHFFFAOYSA-N 2-[[5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methyl]isoindole-1,3-dione Chemical compound NC1=NN=C(CN2C(C3=CC=CC=C3C2=O)=O)C1=NNC1=CC=CC(F)=C1 MIODETWMLAEHPG-UHFFFAOYSA-N 0.000 claims 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- RHODIABTYWPBQG-UHFFFAOYSA-N 3-[(2e)-2-(3-amino-5-cyclopropylpyrazol-4-ylidene)hydrazinyl]-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=CC(NN=C2C(=NN=C2N)C2CC2)=C1 RHODIABTYWPBQG-UHFFFAOYSA-N 0.000 claims 2
- SUIXEXSESNJNEG-UHFFFAOYSA-N 3-[(2z)-2-(3-amino-5-morpholin-4-ylpyrazol-4-ylidene)hydrazinyl]-n-(2-hydroxyethyl)benzenesulfonamide Chemical compound C=1C=CC(S(=O)(=O)NCCO)=CC=1NN=C1C(N)=NN=C1N1CCOCC1 SUIXEXSESNJNEG-UHFFFAOYSA-N 0.000 claims 2
- QUSFDIALRZIGOL-UHFFFAOYSA-N 3-[(2z)-2-(3-amino-5-morpholin-4-ylpyrazol-4-ylidene)hydrazinyl]-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=CC(NN=C2C(=NN=C2N)N2CCOCC2)=C1 QUSFDIALRZIGOL-UHFFFAOYSA-N 0.000 claims 2
- LHSSZWORPJOQLP-UHFFFAOYSA-N 3-[(2z)-2-(3-amino-5-pyrrolidin-1-ylpyrazol-4-ylidene)hydrazinyl]-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=CC(NN=C2C(=NN=C2N)N2CCCC2)=C1 LHSSZWORPJOQLP-UHFFFAOYSA-N 0.000 claims 2
- LTDCERVKAGJVMY-UHFFFAOYSA-N 3-[(2z)-2-(3-amino-5-pyrrolidin-1-ylpyrazol-4-ylidene)hydrazinyl]benzenesulfonamide Chemical compound C=1C=CC(S(N)(=O)=O)=CC=1NN=C1C(N)=NN=C1N1CCCC1 LTDCERVKAGJVMY-UHFFFAOYSA-N 0.000 claims 2
- HTZSGNXPBRUKAJ-UHFFFAOYSA-N 3-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]-n-ethylbenzenesulfonamide Chemical compound CCNS(=O)(=O)C1=CC=CC(NN=C2C(=NN=C2N)N)=C1 HTZSGNXPBRUKAJ-UHFFFAOYSA-N 0.000 claims 2
- FJBAGQFQPZKKMW-UHFFFAOYSA-N 3-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=CC(NN=C2C(=NN=C2N)N)=C1 FJBAGQFQPZKKMW-UHFFFAOYSA-N 0.000 claims 2
- LCQNXRGFMXJDJJ-UHFFFAOYSA-N 3-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]phenol Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC(O)=C1 LCQNXRGFMXJDJJ-UHFFFAOYSA-N 0.000 claims 2
- NJYXSHDYBYOZBK-UHFFFAOYSA-N 3-[2-[3-amino-5-(dimethylamino)pyrazol-4-ylidene]hydrazinyl]-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=CC(NN=C2C(=NN=C2N)N(C)C)=C1 NJYXSHDYBYOZBK-UHFFFAOYSA-N 0.000 claims 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- VZOGFSORINPSIG-UHFFFAOYSA-N 4-(1,3-benzothiazol-2-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=NC2=CC=CC=C2S1 VZOGFSORINPSIG-UHFFFAOYSA-N 0.000 claims 2
- FPODTKKZLBYTCE-UHFFFAOYSA-N 4-(1h-1,2,4-triazol-5-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=NN=CN1 FPODTKKZLBYTCE-UHFFFAOYSA-N 0.000 claims 2
- YLUOVVHTIJCVGM-UHFFFAOYSA-N 4-(1h-indazol-5-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(NN=C2)C2=C1 YLUOVVHTIJCVGM-UHFFFAOYSA-N 0.000 claims 2
- SYDRIGRFPHLLIL-UHFFFAOYSA-N 4-(1h-pyrazol-5-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=NNC=C1 SYDRIGRFPHLLIL-UHFFFAOYSA-N 0.000 claims 2
- XUGLMWVAFSJJDF-UHFFFAOYSA-N 4-(2,1,3-benzothiadiazol-4-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC2=NSN=C12 XUGLMWVAFSJJDF-UHFFFAOYSA-N 0.000 claims 2
- LXBFAVNHXSASKP-UHFFFAOYSA-N 4-(2,1,3-benzothiadiazol-5-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC2=NSN=C2C=C1 LXBFAVNHXSASKP-UHFFFAOYSA-N 0.000 claims 2
- OZKUUFRMPGKVGB-UHFFFAOYSA-N 4-(2,3-dihydro-1,4-benzodioxin-6-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(OCCO2)C2=C1 OZKUUFRMPGKVGB-UHFFFAOYSA-N 0.000 claims 2
- NZCBFZLZEYASLT-UHFFFAOYSA-N 4-(2h-benzotriazol-5-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC2=NNN=C2C=C1 NZCBFZLZEYASLT-UHFFFAOYSA-N 0.000 claims 2
- VQTDROFMWROHTG-UHFFFAOYSA-N 4-(3,5-diamino-4-phenyldiazenylpyrazol-1-yl)benzoic acid Chemical compound NC1=NN(C=2C=CC(=CC=2)C(O)=O)C(N)=C1N=NC1=CC=CC=C1 VQTDROFMWROHTG-UHFFFAOYSA-N 0.000 claims 2
- BLWACJKMLGVWSD-UHFFFAOYSA-N 4-(isoquinolin-5-yldiazenyl)-1-methylpyrazole-3,5-diamine Chemical compound CN1N=C(N)C(N=NC=2C3=CC=NC=C3C=CC=2)=C1N BLWACJKMLGVWSD-UHFFFAOYSA-N 0.000 claims 2
- WXIDXRYWMCOAMZ-UHFFFAOYSA-N 4-(isoquinolin-5-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC2=CN=CC=C12 WXIDXRYWMCOAMZ-UHFFFAOYSA-N 0.000 claims 2
- PGAKGOHRQDUCHZ-UHFFFAOYSA-N 4-(phenylhydrazinylidene)-5-propan-2-ylpyrazol-3-amine Chemical compound CC(C)C1=NN=C(N)C1=NNC1=CC=CC=C1 PGAKGOHRQDUCHZ-UHFFFAOYSA-N 0.000 claims 2
- HZQCHRBRMOFLHS-UHFFFAOYSA-N 4-(phenylhydrazinylidene)-5-pyridin-2-ylpyrazol-3-amine Chemical compound NC1=NN=C(C=2N=CC=CC=2)C1=NNC1=CC=CC=C1 HZQCHRBRMOFLHS-UHFFFAOYSA-N 0.000 claims 2
- JWXRFGYPTIMAJG-UHFFFAOYSA-N 4-(phenylhydrazinylidene)-5-quinolin-6-ylpyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C3C=CC=NC3=CC=2)C1=NNC1=CC=CC=C1 JWXRFGYPTIMAJG-UHFFFAOYSA-N 0.000 claims 2
- DVLVZCQECXFKAN-UHFFFAOYSA-N 4-(phenylhydrazinylidene)-5-quinoxalin-2-ylpyrazol-3-amine Chemical compound NC1=NN=C(C=2N=C3C=CC=CC3=NC=2)C1=NNC1=CC=CC=C1 DVLVZCQECXFKAN-UHFFFAOYSA-N 0.000 claims 2
- PLHRCOBFPLCLTB-UHFFFAOYSA-N 4-(phthalazin-5-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC2=CN=NC=C12 PLHRCOBFPLCLTB-UHFFFAOYSA-N 0.000 claims 2
- KAYRKOVMJPWDNO-UHFFFAOYSA-N 4-(pyridin-4-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=NC=C1 KAYRKOVMJPWDNO-UHFFFAOYSA-N 0.000 claims 2
- JXSAUZNHZQMFRG-UHFFFAOYSA-N 4-(quinazolin-6-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(N=CN=C2)C2=C1 JXSAUZNHZQMFRG-UHFFFAOYSA-N 0.000 claims 2
- AFVJBKNXMOEEDH-UHFFFAOYSA-N 4-(quinolin-3-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CN=C(C=CC=C2)C2=C1 AFVJBKNXMOEEDH-UHFFFAOYSA-N 0.000 claims 2
- VPPLMIWRUDTRMX-UHFFFAOYSA-N 4-(quinolin-5-yldiazenyl)-1H-pyrazole-3,5-diamine Chemical compound NC1=NNC(N)=C1N=NC1=CC=CC2=NC=CC=C12 VPPLMIWRUDTRMX-UHFFFAOYSA-N 0.000 claims 2
- VGUAVKPBURZYFP-UHFFFAOYSA-N 4-(quinolin-6-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(N=CC=C2)C2=C1 VGUAVKPBURZYFP-UHFFFAOYSA-N 0.000 claims 2
- HVLNCWLDCPOSJM-UHFFFAOYSA-N 4-(quinolin-8-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC2=CC=CN=C12 HVLNCWLDCPOSJM-UHFFFAOYSA-N 0.000 claims 2
- LAUVWKRSNDAGJJ-UHFFFAOYSA-N 4-[(1,1-dioxo-1-benzothiophen-6-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(C=CS2(=O)=O)C2=C1 LAUVWKRSNDAGJJ-UHFFFAOYSA-N 0.000 claims 2
- FGKNJBGUMSBLLY-UHFFFAOYSA-N 4-[(1-methylbenzotriazol-5-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound C=1C=C2N(C)N=NC2=CC=1NN=C1C(N)=NN=C1N FGKNJBGUMSBLLY-UHFFFAOYSA-N 0.000 claims 2
- SHISAUBIDDYUEF-UHFFFAOYSA-N 4-[(2,2,3,3-tetrafluoro-1,4-benzodioxin-6-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(OC(F)(F)C(F)(F)O2)C2=C1 SHISAUBIDDYUEF-UHFFFAOYSA-N 0.000 claims 2
- VGTFEMDPDAWVHL-UHFFFAOYSA-N 4-[(2,2-difluoro-1,3-benzodioxol-5-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(OC(F)(F)O2)C2=C1 VGTFEMDPDAWVHL-UHFFFAOYSA-N 0.000 claims 2
- ZCEIXBFAYDUGHP-UHFFFAOYSA-N 4-[(2,3,4,5,6-pentafluorophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=C(F)C(F)=C(F)C(F)=C1F ZCEIXBFAYDUGHP-UHFFFAOYSA-N 0.000 claims 2
- LEVNSQBSJWGBPB-UHFFFAOYSA-N 4-[(2,3,4-trifluorophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(F)C(F)=C1F LEVNSQBSJWGBPB-UHFFFAOYSA-N 0.000 claims 2
- JEQORHSNDXKPOB-UHFFFAOYSA-N 4-[(2,6-dichloropyridin-3-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(Cl)N=C1Cl JEQORHSNDXKPOB-UHFFFAOYSA-N 0.000 claims 2
- UHKWZJPIWZBMBQ-UHFFFAOYSA-N 4-[(2,6-difluorophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=C(F)C=CC=C1F UHKWZJPIWZBMBQ-UHFFFAOYSA-N 0.000 claims 2
- BNZCQPDHOFTAOI-UHFFFAOYSA-N 4-[(2,6-dimethoxypyridin-3-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound COC1=NC(OC)=CC=C1NN=C1C(N)=NN=C1N BNZCQPDHOFTAOI-UHFFFAOYSA-N 0.000 claims 2
- ZUAKKGRBCCBNST-UHFFFAOYSA-N 4-[(2-bromophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC=C1Br ZUAKKGRBCCBNST-UHFFFAOYSA-N 0.000 claims 2
- KUTLYOMFYHFOCV-UHFFFAOYSA-N 4-[(2-methyl-4-morpholin-4-ylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound CC1=CC(N2CCOCC2)=CC=C1NN=C1C(N)=NN=C1N KUTLYOMFYHFOCV-UHFFFAOYSA-N 0.000 claims 2
- IDSDDJPKGOZETE-UHFFFAOYSA-N 4-[(2-methyl-5-nitrophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound CC1=CC=C([N+]([O-])=O)C=C1NN=C1C(N)=NN=C1N IDSDDJPKGOZETE-UHFFFAOYSA-N 0.000 claims 2
- VLZPUXIGSQGLID-UHFFFAOYSA-N 4-[(2-methylbenzotriazol-5-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound C=1C2=NN(C)N=C2C=CC=1NN=C1C(N)=NN=C1N VLZPUXIGSQGLID-UHFFFAOYSA-N 0.000 claims 2
- RLJNJAWAAPGXLH-UHFFFAOYSA-N 4-[(2-propan-2-ylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound CC(C)C1=CC=CC=C1NN=C1C(N)=NN=C1N RLJNJAWAAPGXLH-UHFFFAOYSA-N 0.000 claims 2
- CIVHPCTUPSAMHN-UHFFFAOYSA-N 4-[(2z)-2-(3-amino-5-pyrrolidin-1-ylpyrazol-4-ylidene)hydrazinyl]benzenesulfonamide Chemical compound C=1C=C(S(N)(=O)=O)C=CC=1NN=C1C(N)=NN=C1N1CCCC1 CIVHPCTUPSAMHN-UHFFFAOYSA-N 0.000 claims 2
- OVKFPWXRSHFTPD-UHFFFAOYSA-N 4-[(2z)-2-[3-amino-5-(4-methylpiperazin-1-yl)pyrazol-4-ylidene]hydrazinyl]benzenesulfonamide Chemical compound C1CN(C)CCN1C1=NN=C(N)C1=NNC1=CC=C(S(N)(=O)=O)C=C1 OVKFPWXRSHFTPD-UHFFFAOYSA-N 0.000 claims 2
- LFHCKFDGKBZVTA-UHFFFAOYSA-N 4-[(3,4-dichlorophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(Cl)C(Cl)=C1 LFHCKFDGKBZVTA-UHFFFAOYSA-N 0.000 claims 2
- WZRHAXSZFLFKOJ-UHFFFAOYSA-N 4-[(3,4-difluorophenyl)hydrazinylidene]-5-(morpholin-4-ylmethyl)pyrazol-3-amine Chemical compound C=1C=C(F)C(F)=CC=1NN=C1C(N)=NN=C1CN1CCOCC1 WZRHAXSZFLFKOJ-UHFFFAOYSA-N 0.000 claims 2
- NONAXIPALYRROA-UHFFFAOYSA-N 4-[(3,4-difluorophenyl)hydrazinylidene]-5-methylpyrazol-3-amine Chemical compound CC1=NN=C(N)C1=NNC1=CC=C(F)C(F)=C1 NONAXIPALYRROA-UHFFFAOYSA-N 0.000 claims 2
- LLVAMVRACVTTTO-UHFFFAOYSA-N 4-[(3,4-difluorophenyl)hydrazinylidene]pyrazol-3-amine Chemical compound NC1=NN=CC1=NNC1=CC=C(F)C(F)=C1 LLVAMVRACVTTTO-UHFFFAOYSA-N 0.000 claims 2
- PWEAHERYYKPSFD-UHFFFAOYSA-N 4-[(3,4-difluorophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(F)C(F)=C1 PWEAHERYYKPSFD-UHFFFAOYSA-N 0.000 claims 2
- KLEFDCUJYZYHSA-UHFFFAOYSA-N 4-[(3,4-dimethoxyphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1=C(OC)C(OC)=CC=C1NN=C1C(N)=NN=C1N KLEFDCUJYZYHSA-UHFFFAOYSA-N 0.000 claims 2
- GLBXAOTUZCTMKS-UHFFFAOYSA-N 4-[(3,5-dichlorophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC(Cl)=CC(Cl)=C1 GLBXAOTUZCTMKS-UHFFFAOYSA-N 0.000 claims 2
- SJGTVWJCHMOQAW-UHFFFAOYSA-N 4-[(3,5-difluorophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC(F)=CC(F)=C1 SJGTVWJCHMOQAW-UHFFFAOYSA-N 0.000 claims 2
- BITQYWJQUDAZDZ-UHFFFAOYSA-N 4-[(3-bromophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC(Br)=C1 BITQYWJQUDAZDZ-UHFFFAOYSA-N 0.000 claims 2
- NRJOBBUFSUBINP-UHFFFAOYSA-N 4-[(3-chloro-4-methoxyphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1=C(Cl)C(OC)=CC=C1NN=C1C(N)=NN=C1N NRJOBBUFSUBINP-UHFFFAOYSA-N 0.000 claims 2
- JCFVYHNWYLZMOJ-UHFFFAOYSA-N 4-[(3-chloro-4-morpholin-4-ylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC(C=C1Cl)=CC=C1N1CCOCC1 JCFVYHNWYLZMOJ-UHFFFAOYSA-N 0.000 claims 2
- XESXQAOHYMNIFG-UHFFFAOYSA-N 4-[(3-ethylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound CCC1=CC=CC(NN=C2C(=NN=C2N)N)=C1 XESXQAOHYMNIFG-UHFFFAOYSA-N 0.000 claims 2
- ZUHNSFRXVSRTDR-UHFFFAOYSA-N 4-[(3-fluoro-4-methoxyphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1=C(F)C(OC)=CC=C1NN=C1C(N)=NN=C1N ZUHNSFRXVSRTDR-UHFFFAOYSA-N 0.000 claims 2
- VHPBXKINPYICLL-UHFFFAOYSA-N 4-[(3-fluorophenyl)hydrazinylidene]-5-(3-morpholin-4-ylpropyl)pyrazol-3-amine Chemical compound C=1C=CC(F)=CC=1NN=C1C(N)=NN=C1CCCN1CCOCC1 VHPBXKINPYICLL-UHFFFAOYSA-N 0.000 claims 2
- OSOIRDCVQFNKBI-UHFFFAOYSA-N 4-[(3-iodophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC(I)=C1 OSOIRDCVQFNKBI-UHFFFAOYSA-N 0.000 claims 2
- RNSZEDRJCFFWBL-UHFFFAOYSA-N 4-[(3-methylbenzotriazol-5-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1=C2N(C)N=NC2=CC=C1NN=C1C(N)=NN=C1N RNSZEDRJCFFWBL-UHFFFAOYSA-N 0.000 claims 2
- DYCXXNQEOSLRPA-UHFFFAOYSA-N 4-[(3-methylsulfanylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound CSC1=CC=CC(NN=C2C(=NN=C2N)N)=C1 DYCXXNQEOSLRPA-UHFFFAOYSA-N 0.000 claims 2
- SWMNDJWTLOCMPN-UHFFFAOYSA-N 4-[(3-methylsulfonylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound CS(=O)(=O)C1=CC=CC(NN=C2C(=NN=C2N)N)=C1 SWMNDJWTLOCMPN-UHFFFAOYSA-N 0.000 claims 2
- JDBCFQBKQVPUGW-UHFFFAOYSA-N 4-[(3-phenoxyphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC(OC=2C=CC=CC=2)=C1 JDBCFQBKQVPUGW-UHFFFAOYSA-N 0.000 claims 2
- LHMIWKGTHVHONG-UHFFFAOYSA-N 4-[(3-phenylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC(C=2C=CC=CC=2)=C1 LHMIWKGTHVHONG-UHFFFAOYSA-N 0.000 claims 2
- ILUBMGCQMKKYJO-UHFFFAOYSA-N 4-[(4-anilinophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC(C=C1)=CC=C1NC1=CC=CC=C1 ILUBMGCQMKKYJO-UHFFFAOYSA-N 0.000 claims 2
- CYVYICZTQSDTOS-UHFFFAOYSA-N 4-[(4-benzylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC(C=C1)=CC=C1CC1=CC=CC=C1 CYVYICZTQSDTOS-UHFFFAOYSA-N 0.000 claims 2
- HNFHHGGCNGLDDX-UHFFFAOYSA-N 4-[(4-bromonaphthalen-1-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(Br)C2=CC=CC=C12 HNFHHGGCNGLDDX-UHFFFAOYSA-N 0.000 claims 2
- HEXGYJPHYGRRER-UHFFFAOYSA-N 4-[(4-fluorophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(F)C=C1 HEXGYJPHYGRRER-UHFFFAOYSA-N 0.000 claims 2
- AGBHWUBSXNFLGS-UHFFFAOYSA-N 4-[(4-iodophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(I)C=C1 AGBHWUBSXNFLGS-UHFFFAOYSA-N 0.000 claims 2
- UKADBJVNJWDGOZ-UHFFFAOYSA-N 4-[(4-methoxy-3-nitrophenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1=C([N+]([O-])=O)C(OC)=CC=C1NN=C1C(N)=NN=C1N UKADBJVNJWDGOZ-UHFFFAOYSA-N 0.000 claims 2
- XMZFUSOZTUPHRA-UHFFFAOYSA-N 4-[(4-methoxyphenyl)hydrazinylidene]-5-methylpyrazol-3-amine Chemical compound C1=CC(OC)=CC=C1NN=C1C(N)=NN=C1C XMZFUSOZTUPHRA-UHFFFAOYSA-N 0.000 claims 2
- ACTGZYZTMAGKBM-UHFFFAOYSA-N 4-[(4-methyl-3-morpholin-4-ylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1=C(N2CCOCC2)C(C)=CC=C1NN=C1C(N)=NN=C1N ACTGZYZTMAGKBM-UHFFFAOYSA-N 0.000 claims 2
- HYVDTUJBZBTGKJ-UHFFFAOYSA-N 4-[(4-methylpyridin-3-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound CC1=CC=NC=C1NN=C1C(N)=NN=C1N HYVDTUJBZBTGKJ-UHFFFAOYSA-N 0.000 claims 2
- VFJGWZNENMTFCI-UHFFFAOYSA-N 4-[(4-methylsulfanylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1=CC(SC)=CC=C1NN=C1C(N)=NN=C1N VFJGWZNENMTFCI-UHFFFAOYSA-N 0.000 claims 2
- LVAXTFMEIFHCBR-UHFFFAOYSA-N 4-[(4-methylsulfonylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1NN=C1C(N)=NN=C1N LVAXTFMEIFHCBR-UHFFFAOYSA-N 0.000 claims 2
- UUGZLZHDMUQIEJ-UHFFFAOYSA-N 4-[(4-morpholin-4-ylsulfonylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(S(=O)(=O)N2CCOCC2)C=C1 UUGZLZHDMUQIEJ-UHFFFAOYSA-N 0.000 claims 2
- NZKMCRKXUOELFN-UHFFFAOYSA-N 4-[(4-phenoxyphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC(C=C1)=CC=C1OC1=CC=CC=C1 NZKMCRKXUOELFN-UHFFFAOYSA-N 0.000 claims 2
- ZVGKPZWQFQKOTD-UHFFFAOYSA-N 4-[(4-phenylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(C=2C=CC=CC=2)C=C1 ZVGKPZWQFQKOTD-UHFFFAOYSA-N 0.000 claims 2
- MBDCGUWTYFSKPK-UHFFFAOYSA-N 4-[(4-piperidin-1-ylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(N2CCCCC2)C=C1 MBDCGUWTYFSKPK-UHFFFAOYSA-N 0.000 claims 2
- BKMLNKMFMALHGR-UHFFFAOYSA-N 4-[(4-pyrrolidin-1-ylsulfonylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(S(=O)(=O)N2CCCC2)C=C1 BKMLNKMFMALHGR-UHFFFAOYSA-N 0.000 claims 2
- AVZANNIQDODVPK-UHFFFAOYSA-N 4-[(4z)-5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]benzoic acid Chemical compound NC1=NN=C(C=2C=CC(=CC=2)C(O)=O)C1=NNC1=CC=CC(F)=C1 AVZANNIQDODVPK-UHFFFAOYSA-N 0.000 claims 2
- LCDNRLOMCIALHQ-UHFFFAOYSA-N 4-[(5-methoxy-1,3-benzothiazol-2-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound N=1C2=CC(OC)=CC=C2SC=1NN=C1C(N)=NN=C1N LCDNRLOMCIALHQ-UHFFFAOYSA-N 0.000 claims 2
- VNPYJZGIYBYVCZ-UHFFFAOYSA-N 4-[(6-chloropyridin-3-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(Cl)N=C1 VNPYJZGIYBYVCZ-UHFFFAOYSA-N 0.000 claims 2
- KJJQTZARCNGDPP-UHFFFAOYSA-N 4-[(6-fluoropyridin-3-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(F)N=C1 KJJQTZARCNGDPP-UHFFFAOYSA-N 0.000 claims 2
- BHLUYAROZQEDOZ-UHFFFAOYSA-N 4-[(6-methoxypyridin-3-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1=NC(OC)=CC=C1NN=C1C(N)=NN=C1N BHLUYAROZQEDOZ-UHFFFAOYSA-N 0.000 claims 2
- IROJQICVHPPBRP-UHFFFAOYSA-N 4-[(6-morpholin-4-ylpyridin-3-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(N2CCOCC2)N=C1 IROJQICVHPPBRP-UHFFFAOYSA-N 0.000 claims 2
- KKYMGLKCALSWMO-UHFFFAOYSA-N 4-[(6-piperidin-1-ylpyridin-3-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(N2CCCCC2)N=C1 KKYMGLKCALSWMO-UHFFFAOYSA-N 0.000 claims 2
- VAAUYDWUHKXQLY-UHFFFAOYSA-N 4-[(9-ethylcarbazol-3-yl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound C=1C=C2N(CC)C3=CC=CC=C3C2=CC=1NN=C1C(N)=NN=C1N VAAUYDWUHKXQLY-UHFFFAOYSA-N 0.000 claims 2
- ADMCEWNYPAOKFP-UHFFFAOYSA-N 4-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]-n-(2,6-dimethylpyrimidin-4-yl)benzenesulfonamide Chemical compound CC1=NC(C)=CC(NS(=O)(=O)C=2C=CC(NN=C3C(=NN=C3N)N)=CC=2)=N1 ADMCEWNYPAOKFP-UHFFFAOYSA-N 0.000 claims 2
- VUVGJXROVOASCQ-UHFFFAOYSA-N 4-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]-n-ethylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)NCC)=CC=C1NN=C1C(N)=NN=C1N VUVGJXROVOASCQ-UHFFFAOYSA-N 0.000 claims 2
- CKWHIDHJZNTSFQ-UHFFFAOYSA-N 4-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]-n-methylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)NC)=CC=C1NN=C1C(N)=NN=C1N CKWHIDHJZNTSFQ-UHFFFAOYSA-N 0.000 claims 2
- USDDAUQNOXISQF-UHFFFAOYSA-N 4-[[2,3-difluoro-4-(trifluoromethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(C(F)(F)F)C(F)=C1F USDDAUQNOXISQF-UHFFFAOYSA-N 0.000 claims 2
- VEUAEELGXHDJTG-UHFFFAOYSA-N 4-[[2-(benzenesulfonyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC=C1S(=O)(=O)C1=CC=CC=C1 VEUAEELGXHDJTG-UHFFFAOYSA-N 0.000 claims 2
- YPCLLZPOBUFZFR-UHFFFAOYSA-N 4-[[3-(diethylaminomethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound CCN(CC)CC1=CC=CC(NN=C2C(=NN=C2N)N)=C1 YPCLLZPOBUFZFR-UHFFFAOYSA-N 0.000 claims 2
- ZXCCFKRQIFPALL-UHFFFAOYSA-N 4-[[3-(morpholin-4-ylmethyl)-5-(trifluoromethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC(CN2CCOCC2)=CC(C(F)(F)F)=C1 ZXCCFKRQIFPALL-UHFFFAOYSA-N 0.000 claims 2
- WGHKLKZBVIICCR-UHFFFAOYSA-N 4-[[3-(morpholin-4-ylmethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC(CN2CCOCC2)=C1 WGHKLKZBVIICCR-UHFFFAOYSA-N 0.000 claims 2
- WHPMUGPULQQXBI-UHFFFAOYSA-N 4-[[3-(piperidin-1-ylmethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC(CN2CCCCC2)=C1 WHPMUGPULQQXBI-UHFFFAOYSA-N 0.000 claims 2
- VAJBUYAUWRFIRT-UHFFFAOYSA-N 4-[[3-(pyrrolidin-1-ylmethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC(CN2CCCC2)=C1 VAJBUYAUWRFIRT-UHFFFAOYSA-N 0.000 claims 2
- PTGIUDNMMLWFCI-UHFFFAOYSA-N 4-[[3-(trifluoromethoxy)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC(OC(F)(F)F)=C1 PTGIUDNMMLWFCI-UHFFFAOYSA-N 0.000 claims 2
- SVZYIZZHGRDLDA-UHFFFAOYSA-N 4-[[3-(trifluoromethylsulfonyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=CC(S(=O)(=O)C(F)(F)F)=C1 SVZYIZZHGRDLDA-UHFFFAOYSA-N 0.000 claims 2
- HOYGPQALOHHUTF-UHFFFAOYSA-N 4-[[3-[(4-methylpiperazin-1-yl)methyl]phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1CN(C)CCN1CC1=CC=CC(NN=C2C(=NN=C2N)N)=C1 HOYGPQALOHHUTF-UHFFFAOYSA-N 0.000 claims 2
- FTPKBUBZDIJYJG-UHFFFAOYSA-N 4-[[3-[(dimethylamino)methyl]phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound CN(C)CC1=CC=CC(NN=C2C(=NN=C2N)N)=C1 FTPKBUBZDIJYJG-UHFFFAOYSA-N 0.000 claims 2
- HRFHJUXFZAIGHZ-UHFFFAOYSA-N 4-[[3-[2-(2-methoxyethoxy)ethoxymethyl]phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound COCCOCCOCC1=CC=CC(NN=C2C(=NN=C2N)N)=C1 HRFHJUXFZAIGHZ-UHFFFAOYSA-N 0.000 claims 2
- KKIQMAZVFOEUPD-UHFFFAOYSA-N 4-[[3-fluoro-4-(morpholin-4-ylmethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC(C=C1F)=CC=C1CN1CCOCC1 KKIQMAZVFOEUPD-UHFFFAOYSA-N 0.000 claims 2
- QIDWETIPOWISMD-UHFFFAOYSA-N 4-[[3-fluoro-5-(trifluoromethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC(F)=CC(C(F)(F)F)=C1 QIDWETIPOWISMD-UHFFFAOYSA-N 0.000 claims 2
- WRRTWGQFLSZBFW-UHFFFAOYSA-N 4-[[4-(2-morpholin-4-ylethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC(C=C1)=CC=C1CCN1CCOCC1 WRRTWGQFLSZBFW-UHFFFAOYSA-N 0.000 claims 2
- KDAGZCFSQPZWAL-UHFFFAOYSA-N 4-[[4-(diethoxyphosphorylmethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1=CC(CP(=O)(OCC)OCC)=CC=C1NN=C1C(N)=NN=C1N KDAGZCFSQPZWAL-UHFFFAOYSA-N 0.000 claims 2
- YZBFMEVYGFYHPT-UHFFFAOYSA-N 4-[[4-(morpholin-4-ylmethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC(C=C1)=CC=C1CN1CCOCC1 YZBFMEVYGFYHPT-UHFFFAOYSA-N 0.000 claims 2
- WDKIOMUEDUOZCK-UHFFFAOYSA-N 4-[[4-(piperidin-1-ylmethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC(C=C1)=CC=C1CN1CCCCC1 WDKIOMUEDUOZCK-UHFFFAOYSA-N 0.000 claims 2
- HZSGEKAWGQFQOA-UHFFFAOYSA-N 4-[[4-(trifluoromethyl)phenyl]diazenyl]-1H-pyrazole-3,5-diamine Chemical compound NC1=NNC(=C1N=NC1=CC=C(C=C1)C(F)(F)F)N HZSGEKAWGQFQOA-UHFFFAOYSA-N 0.000 claims 2
- NSYWAIJQKAUUSD-UHFFFAOYSA-N 4-[[4-(trifluoromethylsulfonyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 NSYWAIJQKAUUSD-UHFFFAOYSA-N 0.000 claims 2
- FJICOWBLPAPWRJ-UHFFFAOYSA-N 4-[[4-[(4-methylpiperazin-1-yl)methyl]phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1CN(C)CCN1CC(C=C1)=CC=C1NN=C1C(N)=NN=C1N FJICOWBLPAPWRJ-UHFFFAOYSA-N 0.000 claims 2
- XLSVRHLNTHJXKB-UHFFFAOYSA-N 4-[[4-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]phenyl]methylamino]-1,2,5-thiadiazole-3-carboxamide Chemical compound NC(=O)C1=NSN=C1NCC(C=C1)=CC=C1NN=C1C(N)=NN=C1N XLSVRHLNTHJXKB-UHFFFAOYSA-N 0.000 claims 2
- ZOCKLXGZLZGVJG-UHFFFAOYSA-N 4-[[4-[[4-(methylamino)phenyl]methyl]phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1=CC(NC)=CC=C1CC(C=C1)=CC=C1NN=C1C(N)=NN=C1N ZOCKLXGZLZGVJG-UHFFFAOYSA-N 0.000 claims 2
- FGQUTFXNNJWKNA-UHFFFAOYSA-N 4-[[4-chloro-3-(trifluoromethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(Cl)C(C(F)(F)F)=C1 FGQUTFXNNJWKNA-UHFFFAOYSA-N 0.000 claims 2
- LSVVFCHEZSQBCU-UHFFFAOYSA-N 4-[[4-fluoro-2-(morpholin-4-ylmethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(F)C=C1CN1CCOCC1 LSVVFCHEZSQBCU-UHFFFAOYSA-N 0.000 claims 2
- CMJFUENRZNTBIB-UHFFFAOYSA-N 4-[[4-methoxy-3-(morpholin-4-ylmethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1=C(CN2CCOCC2)C(OC)=CC=C1NN=C1C(N)=NN=C1N CMJFUENRZNTBIB-UHFFFAOYSA-N 0.000 claims 2
- PPGWWRSQTVTLSI-UHFFFAOYSA-N 4-[[4-nitro-3-(trifluoromethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 PPGWWRSQTVTLSI-UHFFFAOYSA-N 0.000 claims 2
- LKOCQSBVIKJBCY-UHFFFAOYSA-N 4-[[5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methylamino]-4-oxobut-2-enoic acid Chemical compound NC1=NN=C(CNC(=O)C=CC(O)=O)C1=NNC1=CC=CC(F)=C1 LKOCQSBVIKJBCY-UHFFFAOYSA-N 0.000 claims 2
- FICPEKCRSCJDBN-UHFFFAOYSA-N 4-[[5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methylamino]-4-oxobutanoic acid Chemical compound NC1=NN=C(CNC(=O)CCC(O)=O)C1=NNC1=CC=CC(F)=C1 FICPEKCRSCJDBN-UHFFFAOYSA-N 0.000 claims 2
- VGKHLSWLWMNITK-UHFFFAOYSA-N 4-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound C1CN(C)CCN1C(N=C1)=CC=C1NN=C1C(N)=NN=C1N VGKHLSWLWMNITK-UHFFFAOYSA-N 0.000 claims 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 2
- RTFWUSQIRVGRFW-UHFFFAOYSA-N 5-(1,3-benzodioxol-5-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C3OCOC3=CC=2)C1=NNC1=CC=CC=C1 RTFWUSQIRVGRFW-UHFFFAOYSA-N 0.000 claims 2
- FOXXFRSQQCTDMI-UHFFFAOYSA-N 5-(1-benzothiophen-2-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2SC3=CC=CC=C3C=2)C1=NNC1=CC=CC=C1 FOXXFRSQQCTDMI-UHFFFAOYSA-N 0.000 claims 2
- RSHYOOHKYMQVFK-UHFFFAOYSA-N 5-(1-benzothiophen-3-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C3=CC=CC=C3SC=2)C1=NNC1=CC=CC=C1 RSHYOOHKYMQVFK-UHFFFAOYSA-N 0.000 claims 2
- NZXTYBMRFRSNSG-UHFFFAOYSA-N 5-(1-methylpyrrol-2-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound CN1C=CC=C1C1=NN=C(N)C1=NNC1=CC=CC=C1 NZXTYBMRFRSNSG-UHFFFAOYSA-N 0.000 claims 2
- FMGBOROHMSNDQG-UHFFFAOYSA-N 5-(2,2-dimethylpropyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound CC(C)(C)CC1=NN=C(N)C1=NNC1=CC=CC=C1 FMGBOROHMSNDQG-UHFFFAOYSA-N 0.000 claims 2
- OVBJQXQGUVDTNZ-UHFFFAOYSA-N 5-(2-chloropyridin-4-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C(Cl)N=CC=2)C1=NNC1=CC=CC=C1 OVBJQXQGUVDTNZ-UHFFFAOYSA-N 0.000 claims 2
- QQTMQNZCRUHENH-UHFFFAOYSA-N 5-(2-fluorophenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C(=CC=CC=2)F)C1=NNC1=CC=CC=C1 QQTMQNZCRUHENH-UHFFFAOYSA-N 0.000 claims 2
- YRPYCIYRKPMPCH-UHFFFAOYSA-N 5-(2-methylfuran-3-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound O1C=CC(C=2C(C(N)=NN=2)=NNC=2C=CC=CC=2)=C1C YRPYCIYRKPMPCH-UHFFFAOYSA-N 0.000 claims 2
- QIZUDBJBKRIKQQ-UHFFFAOYSA-N 5-(2-methylpropyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound CC(C)CC1=NN=C(N)C1=NNC1=CC=CC=C1 QIZUDBJBKRIKQQ-UHFFFAOYSA-N 0.000 claims 2
- JJFHOHRRRNENSP-UHFFFAOYSA-N 5-(2-methylsulfanylethyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound CSCCC1=NN=C(N)C1=NNC1=CC=CC=C1 JJFHOHRRRNENSP-UHFFFAOYSA-N 0.000 claims 2
- BBCKFPPMFXXVAS-UHFFFAOYSA-N 5-(2-morpholin-4-ylethyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C=1C=CC=CC=1NN=C1C(N)=NN=C1CCN1CCOCC1 BBCKFPPMFXXVAS-UHFFFAOYSA-N 0.000 claims 2
- YXERFNGILJXRSV-UHFFFAOYSA-N 5-(2-nitrophenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C(=CC=CC=2)[N+]([O-])=O)C1=NNC1=CC=CC=C1 YXERFNGILJXRSV-UHFFFAOYSA-N 0.000 claims 2
- QZXFGQZBJQYRMH-UHFFFAOYSA-N 5-(2-phenylcyclopropyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C=1C=CC=CC=1NN=C1C(N)=NN=C1C1CC1C1=CC=CC=C1 QZXFGQZBJQYRMH-UHFFFAOYSA-N 0.000 claims 2
- OACMZUMBPDAWPN-UHFFFAOYSA-N 5-(2-phenylethyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C=1C=CC=CC=1NN=C1C(N)=NN=C1CCC1=CC=CC=C1 OACMZUMBPDAWPN-UHFFFAOYSA-N 0.000 claims 2
- LKSMLPDFAGBCMJ-UHFFFAOYSA-N 5-(3,4-difluorophenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C(F)C(F)=CC=2)C1=NNC1=CC=CC=C1 LKSMLPDFAGBCMJ-UHFFFAOYSA-N 0.000 claims 2
- JVKCPNUQQNCTON-UHFFFAOYSA-N 5-(3,4-dimethoxyphenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C1=C(OC)C(OC)=CC=C1C1=NN=C(N)C1=NNC1=CC=CC=C1 JVKCPNUQQNCTON-UHFFFAOYSA-N 0.000 claims 2
- KTQRJDQYICVZNU-UHFFFAOYSA-N 5-(3,4-dimethylphenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C1=C(C)C(C)=CC=C1C1=NN=C(N)C1=NNC1=CC=CC=C1 KTQRJDQYICVZNU-UHFFFAOYSA-N 0.000 claims 2
- OBNQWRKOEVWXKD-UHFFFAOYSA-N 5-(3,5-difluorophenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C(F)C=C(F)C=2)C1=NNC1=CC=CC=C1 OBNQWRKOEVWXKD-UHFFFAOYSA-N 0.000 claims 2
- APSMFRSWHBUHNP-UHFFFAOYSA-N 5-(3-aminopropyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NCCCC1=NN=C(N)C1=NNC1=CC=CC=C1 APSMFRSWHBUHNP-UHFFFAOYSA-N 0.000 claims 2
- PUYJDVDOOBULEE-UHFFFAOYSA-N 5-(3-bromophenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C(Br)C=CC=2)C1=NNC1=CC=CC=C1 PUYJDVDOOBULEE-UHFFFAOYSA-N 0.000 claims 2
- HYUCRXCWEVKXBQ-UHFFFAOYSA-N 5-(3-chlorothiophen-2-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C2=C(C=CS2)Cl)C1=NNC1=CC=CC=C1 HYUCRXCWEVKXBQ-UHFFFAOYSA-N 0.000 claims 2
- HHYFJXWIXVQQRP-UHFFFAOYSA-N 5-(3-fluorophenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C(F)C=CC=2)C1=NNC1=CC=CC=C1 HHYFJXWIXVQQRP-UHFFFAOYSA-N 0.000 claims 2
- OQKLUOBFXVXOSV-UHFFFAOYSA-N 5-(3-methoxythiophen-2-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C1=CSC(C=2C(C(N)=NN=2)=NNC=2C=CC=CC=2)=C1OC OQKLUOBFXVXOSV-UHFFFAOYSA-N 0.000 claims 2
- WOVXHVUKVNKACF-UHFFFAOYSA-N 5-(3-phenoxypropyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C=1C=CC=CC=1NN=C1C(N)=NN=C1CCCOC1=CC=CC=C1 WOVXHVUKVNKACF-UHFFFAOYSA-N 0.000 claims 2
- OKOFWLVZJMNTRB-UHFFFAOYSA-N 5-(4-fluorophenyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=CC(F)=CC=2)C1=NNC1=CC=CC=C1 OKOFWLVZJMNTRB-UHFFFAOYSA-N 0.000 claims 2
- BIHBMSNFWPUANA-UHFFFAOYSA-N 5-(4-morpholin-4-ylbutyl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C=1C=CC=CC=1NN=C1C(N)=NN=C1CCCCN1CCOCC1 BIHBMSNFWPUANA-UHFFFAOYSA-N 0.000 claims 2
- OCSJEQGWMRVXIL-UHFFFAOYSA-N 5-(5-bromopyridin-3-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C(Br)C=NC=2)C1=NNC1=CC=CC=C1 OCSJEQGWMRVXIL-UHFFFAOYSA-N 0.000 claims 2
- GUYOEHFVJCKLIN-UHFFFAOYSA-N 5-(6-chloropyridin-3-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=NC(Cl)=CC=2)C1=NNC1=CC=CC=C1 GUYOEHFVJCKLIN-UHFFFAOYSA-N 0.000 claims 2
- GQLBDKDCIMPEDP-UHFFFAOYSA-N 5-(aminomethyl)-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-amine Chemical compound NCC1=NN=C(N)C1=NNC1=CC=CC(F)=C1 GQLBDKDCIMPEDP-UHFFFAOYSA-N 0.000 claims 2
- BHEXONBGNZRDMW-UHFFFAOYSA-N 5-[(2e)-2-(3-amino-5-methylpyrazol-4-ylidene)hydrazinyl]-2h-triazole-4-carboxylic acid Chemical compound CC1=NN=C(N)C1=NNC1=NNN=C1C(O)=O BHEXONBGNZRDMW-UHFFFAOYSA-N 0.000 claims 2
- XJZZQQKWMINRLU-UHFFFAOYSA-N 5-[(4-methoxyphenyl)methyl]-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C1=CC(OC)=CC=C1CC1=NN=C(N)\C1=N/NC1=CC=CC=C1 XJZZQQKWMINRLU-UHFFFAOYSA-N 0.000 claims 2
- FZWNSFJETJHGAR-UHFFFAOYSA-N 5-[2-(3-amino-5-methylpyrazol-4-ylidene)hydrazinyl]-1h-pyrazole-4-carboxylic acid Chemical compound CC1=NN=C(N)C1=NNC1=NNC=C1C(O)=O FZWNSFJETJHGAR-UHFFFAOYSA-N 0.000 claims 2
- HHCQXAFFMGGVHQ-UHFFFAOYSA-N 5-[3-[(4-chlorophenyl)sulfanylmethyl]phenyl]-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=C(CSC=3C=CC(Cl)=CC=3)C=CC=2)C1=NNC1=CC=CC=C1 HHCQXAFFMGGVHQ-UHFFFAOYSA-N 0.000 claims 2
- FRVROFMHOJDYAX-UHFFFAOYSA-N 5-[[bis(pyridin-2-ylmethyl)amino]methyl]-4-[(3,4-difluorophenyl)hydrazinylidene]pyrazol-3-amine Chemical compound C=1C=C(F)C(F)=CC=1NN=C1C(N)=NN=C1CN(CC=1N=CC=CC=1)CC1=CC=CC=N1 FRVROFMHOJDYAX-UHFFFAOYSA-N 0.000 claims 2
- SUZXRXHPBRLUJT-UHFFFAOYSA-N 5-[[bis(pyridin-3-ylmethyl)amino]methyl]-4-[(3,4-difluorophenyl)hydrazinylidene]pyrazol-3-amine Chemical compound C=1C=C(F)C(F)=CC=1NN=C1C(N)=NN=C1CN(CC=1C=NC=CC=1)CC1=CC=CN=C1 SUZXRXHPBRLUJT-UHFFFAOYSA-N 0.000 claims 2
- RYOXMHAFINUNGI-UHFFFAOYSA-N 5-benzhydryl-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C=1C=CC=CC=1NN=C1C(N)=NN=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 RYOXMHAFINUNGI-UHFFFAOYSA-N 0.000 claims 2
- OGWRVLCNRLAMHT-UHFFFAOYSA-N 5-but-3-enyl-4-[(3-nitrophenyl)hydrazinylidene]pyrazol-3-amine Chemical compound NC1=NN=C(CCC=C)C1=NNC1=CC=CC([N+]([O-])=O)=C1 OGWRVLCNRLAMHT-UHFFFAOYSA-N 0.000 claims 2
- ITRURQXFYDMLRX-UHFFFAOYSA-N 5-cyclopropyl-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound C=1C=CC=CC=1NN=C1C(N)=NN=C1C1CC1 ITRURQXFYDMLRX-UHFFFAOYSA-N 0.000 claims 2
- UQQONSKFAFDDCJ-UHFFFAOYSA-N 5-ethyl-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound CCC1=NN=C(N)C1=NNC1=CC=CC=C1 UQQONSKFAFDDCJ-UHFFFAOYSA-N 0.000 claims 2
- VUGCEFDMWBWFGM-UHFFFAOYSA-N 5-methyl-4-[[4-(trifluoromethyl)phenyl]hydrazinylidene]pyrazol-3-amine Chemical compound CC1=NN=C(N)C1=NNC1=CC=C(C(F)(F)F)C=C1 VUGCEFDMWBWFGM-UHFFFAOYSA-N 0.000 claims 2
- OQDMHVZMVJNBGQ-UHFFFAOYSA-N 5-n-ethyl-4-(phenylhydrazinylidene)pyrazole-3,5-diamine Chemical compound CCNC1=NN=C(N)C1=NNC1=CC=CC=C1 OQDMHVZMVJNBGQ-UHFFFAOYSA-N 0.000 claims 2
- IVCGXXAZOLGWBG-UHFFFAOYSA-N 5-pentan-3-yl-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound CCC(CC)C1=NN=C(N)C1=NNC1=CC=CC=C1 IVCGXXAZOLGWBG-UHFFFAOYSA-N 0.000 claims 2
- JLDAPWZORHKVCL-UHFFFAOYSA-N 5-phenyl-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound NC1=NN=C(C=2C=CC=CC=2)C1=NNC1=CC=CC=C1 JLDAPWZORHKVCL-UHFFFAOYSA-N 0.000 claims 2
- TUBQABMSERJOCI-UHFFFAOYSA-N 7-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]-4-(trifluoromethyl)-3,4-dihydrochromen-2-one Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(C(CC(=O)O2)C(F)(F)F)C2=C1 TUBQABMSERJOCI-UHFFFAOYSA-N 0.000 claims 2
- ILPKUPISVQDYGU-UHFFFAOYSA-N C1=C(O)C(CN(CC)CC)=CC(NN=C2C(=NN=C2N)N)=C1 Chemical compound C1=C(O)C(CN(CC)CC)=CC(NN=C2C(=NN=C2N)N)=C1 ILPKUPISVQDYGU-UHFFFAOYSA-N 0.000 claims 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 2
- DQIKINKDVJKFKA-UHFFFAOYSA-N FC=1C=C(C=CC1)NN=C1C(=NN=C1C)NC Chemical compound FC=1C=C(C=CC1)NN=C1C(=NN=C1C)NC DQIKINKDVJKFKA-UHFFFAOYSA-N 0.000 claims 2
- QQQIAJCEOKVDKX-UHFFFAOYSA-N FC=1C=C(C=CC1F)NN=C1C(=NN=C1C)NC Chemical compound FC=1C=C(C=CC1F)NN=C1C(=NN=C1C)NC QQQIAJCEOKVDKX-UHFFFAOYSA-N 0.000 claims 2
- BPVICLXZJAVPQU-UHFFFAOYSA-N FC=1C=C(C=CC=1)NN=C1C(=NN=C1C1=CC=NC=C1)NC Chemical compound FC=1C=C(C=CC=1)NN=C1C(=NN=C1C1=CC=NC=C1)NC BPVICLXZJAVPQU-UHFFFAOYSA-N 0.000 claims 2
- 206010020772 Hypertension Diseases 0.000 claims 2
- 208000030289 Lymphoproliferative disease Diseases 0.000 claims 2
- 241000907681 Morpho Species 0.000 claims 2
- ICLOBEAZGADIGT-UHFFFAOYSA-N NC1=NN=C(C1=NNC1=C(C(=C(C=C1)O)N1CCOCC1)C)N Chemical compound NC1=NN=C(C1=NNC1=C(C(=C(C=C1)O)N1CCOCC1)C)N ICLOBEAZGADIGT-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- YGUFMHQFLFQPPV-UHFFFAOYSA-N [3-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]-5-nitrophenyl]methanol Chemical compound NC1=NN=C(N)C1=NNC1=CC(CO)=CC([N+]([O-])=O)=C1 YGUFMHQFLFQPPV-UHFFFAOYSA-N 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- MDZWEJNAWDIQNV-UHFFFAOYSA-N benzyl 3-[[5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methylamino]-3-oxopropanoate Chemical compound C=1C=CC(F)=CC=1NN=C1C(N)=NN=C1CNC(=O)CC(=O)OCC1=CC=CC=C1 MDZWEJNAWDIQNV-UHFFFAOYSA-N 0.000 claims 2
- 230000012292 cell migration Effects 0.000 claims 2
- IIMNZOCCIUNMSH-UHFFFAOYSA-N chembl1401643 Chemical compound NC1=NNC(N)=C1N=NC1=CC=CC(F)=C1 IIMNZOCCIUNMSH-UHFFFAOYSA-N 0.000 claims 2
- HQNMHDJCGMVDTP-UHFFFAOYSA-N chembl1440687 Chemical compound NC1=NNC(N)=C1N=NC1=CC=C(OCO2)C2=C1 HQNMHDJCGMVDTP-UHFFFAOYSA-N 0.000 claims 2
- FYQUIQIJAHNRDC-UHFFFAOYSA-N chembl1516511 Chemical compound NC1=NNC(N)=C1N=NC1=CC=CC(C(F)(F)F)=C1 FYQUIQIJAHNRDC-UHFFFAOYSA-N 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- NUKZIEYXCIOJBZ-UHFFFAOYSA-N ethyl 3-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]benzoate Chemical compound CCOC(=O)C1=CC=CC(NN=C2C(=NN=C2N)N)=C1 NUKZIEYXCIOJBZ-UHFFFAOYSA-N 0.000 claims 2
- RIPIDKJYDJSOIL-UHFFFAOYSA-N ethyl 4-[2-(3,5-diaminopyrazol-4-ylidene)hydrazinyl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1NN=C1C(N)=NN=C1N RIPIDKJYDJSOIL-UHFFFAOYSA-N 0.000 claims 2
- XEIZOPMXGMKTFT-UHFFFAOYSA-N ethyl 5-[2-(3-amino-5-methylpyrazol-4-ylidene)hydrazinyl]-1h-pyrazole-4-carboxylate Chemical compound CCOC(=O)C1=CNN=C1NN=C1C(N)=NN=C1C XEIZOPMXGMKTFT-UHFFFAOYSA-N 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000005638 hydrazono group Chemical group 0.000 claims 2
- 206010020718 hyperplasia Diseases 0.000 claims 2
- 210000002540 macrophage Anatomy 0.000 claims 2
- MXDOHXBAHAHROF-UHFFFAOYSA-N methyl 1-[2-[3,5-diamino-4-(pyridin-3-yldiazenyl)pyrazol-1-yl]-2-oxoethyl]pyrrolidine-2-carboxylate Chemical compound COC(=O)C1CCCN1CC(=O)N1C(N)=C(N=NC=2C=NC=CC=2)C(N)=N1 MXDOHXBAHAHROF-UHFFFAOYSA-N 0.000 claims 2
- DJRQOFXIBCFYOA-UHFFFAOYSA-N methyl 1-[2-[[5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methylamino]-2-oxoethyl]pyrrolidine-2-carboxylate Chemical compound COC(=O)C1CCCN1CC(=O)NCC1=NN=C(N)C1=NNC1=CC=CC(F)=C1 DJRQOFXIBCFYOA-UHFFFAOYSA-N 0.000 claims 2
- UIJMKJNYZOABIN-UHFFFAOYSA-N methyl 1-[4-[[5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methylamino]-4-oxobut-2-enoyl]pyrrolidine-2-carboxylate Chemical compound COC(=O)C1CCCN1C(=O)C=CC(=O)NCC1=NN=C(N)C1=NNC1=CC=CC(F)=C1 UIJMKJNYZOABIN-UHFFFAOYSA-N 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims 2
- 125000006542 morpholinylalkyl group Chemical group 0.000 claims 2
- IYOJYKTXPAJGOO-UHFFFAOYSA-N n-[(3-amino-5-but-3-enylpyrazol-4-ylidene)amino]isoquinolin-5-amine Chemical compound NC1=NN=C(CCC=C)C1=NNC1=CC=CC2=CN=CC=C12 IYOJYKTXPAJGOO-UHFFFAOYSA-N 0.000 claims 2
- LLTYEFXXVCSNRP-UHFFFAOYSA-N n-[(3-amino-5-but-3-enylpyrazol-4-ylidene)amino]quinolin-6-amine Chemical compound NC1=NN=C(CCC=C)C1=NNC1=CC=C(N=CC=C2)C2=C1 LLTYEFXXVCSNRP-UHFFFAOYSA-N 0.000 claims 2
- XKXQIAGVFBYIRU-UHFFFAOYSA-N n-[(3-amino-5-cyclopropylpyrazol-4-ylidene)amino]pyridin-3-amine Chemical compound C=1C=CN=CC=1NN=C1C(N)=NN=C1C1CC1 XKXQIAGVFBYIRU-UHFFFAOYSA-N 0.000 claims 2
- HIKHFHNJFHFKJS-UHFFFAOYSA-N n-[(3-amino-5-methylpyrazol-4-ylidene)amino]-2h-tetrazol-5-amine Chemical compound CC1=NN=C(N)C1=NNC1=NNN=N1 HIKHFHNJFHFKJS-UHFFFAOYSA-N 0.000 claims 2
- UABWIYKAHWCMSW-UHFFFAOYSA-N n-[(3-amino-5-methylpyrazol-4-ylidene)amino]pyridin-3-amine Chemical compound CC1=NN=C(N)C1=NNC1=CC=CN=C1 UABWIYKAHWCMSW-UHFFFAOYSA-N 0.000 claims 2
- OJGUTTDWQXPCCL-UHFFFAOYSA-N n-[(3-amino-5-thiophen-2-ylpyrazol-4-ylidene)amino]pyridin-3-amine Chemical compound NC1=NN=C(C=2SC=CC=2)C1=NNC1=CC=CN=C1 OJGUTTDWQXPCCL-UHFFFAOYSA-N 0.000 claims 2
- ZPLWDDQWYUSABI-UHFFFAOYSA-N n-[(e)-(3-amino-5-methylpyrazol-4-ylidene)amino]-1h-1,2,4-triazol-5-amine Chemical compound CC1=NN=C(N)C1=NNC1=NN=CN1 ZPLWDDQWYUSABI-UHFFFAOYSA-N 0.000 claims 2
- OZHMCIDXCPZBOX-UHFFFAOYSA-N n-[(e)-(3-amino-5-tert-butylpyrazol-4-ylidene)amino]-2h-tetrazol-5-amine Chemical compound CC(C)(C)C1=NN=C(N)C1=NNC1=NN=NN1 OZHMCIDXCPZBOX-UHFFFAOYSA-N 0.000 claims 2
- QRYYAPCZCVPHIA-UHFFFAOYSA-N n-[(e)-[3-amino-5-(1-methylpyrrol-2-yl)pyrazol-4-ylidene]amino]pyridin-3-amine Chemical compound CN1C=CC=C1C1=NN=C(N)C1=NNC1=CC=CN=C1 QRYYAPCZCVPHIA-UHFFFAOYSA-N 0.000 claims 2
- FRFDCYZFABGBGC-UHFFFAOYSA-N n-[(z)-(3-amino-5-morpholin-4-ylpyrazol-4-ylidene)amino]-6-chloropyridin-3-amine Chemical compound C=1C=C(Cl)N=CC=1NN=C1C(N)=NN=C1N1CCOCC1 FRFDCYZFABGBGC-UHFFFAOYSA-N 0.000 claims 2
- WQDZTFYAZHLKSD-UHFFFAOYSA-N n-[(z)-(3-amino-5-morpholin-4-ylpyrazol-4-ylidene)amino]-6-methylpyridin-3-amine Chemical compound C1=NC(C)=CC=C1NN=C1C(N2CCOCC2)=NN=C1N WQDZTFYAZHLKSD-UHFFFAOYSA-N 0.000 claims 2
- BRXNEQZUKLTHRO-UHFFFAOYSA-N n-[(z)-(3-amino-5-morpholin-4-ylpyrazol-4-ylidene)amino]phthalazin-5-amine Chemical compound C=1C=CC2=CN=NC=C2C=1NN=C1C(N)=NN=C1N1CCOCC1 BRXNEQZUKLTHRO-UHFFFAOYSA-N 0.000 claims 2
- VBEPOKRATXIHBU-UHFFFAOYSA-N n-[(z)-(3-amino-5-morpholin-4-ylpyrazol-4-ylidene)amino]pyridin-3-amine Chemical compound C=1C=CN=CC=1NN=C1C(N)=NN=C1N1CCOCC1 VBEPOKRATXIHBU-UHFFFAOYSA-N 0.000 claims 2
- WVMXOWXFZIBOCN-UHFFFAOYSA-N n-[(z)-(3-amino-5-pyrrolidin-1-ylpyrazol-4-ylidene)amino]-6-chloropyridin-3-amine Chemical compound C=1C=C(Cl)N=CC=1NN=C1C(N)=NN=C1N1CCCC1 WVMXOWXFZIBOCN-UHFFFAOYSA-N 0.000 claims 2
- RROPNTBIMNIFQF-UHFFFAOYSA-N n-[(z)-(3-amino-5-pyrrolidin-1-ylpyrazol-4-ylidene)amino]-6-fluoropyridin-3-amine Chemical compound C=1C=C(F)N=CC=1NN=C1C(N)=NN=C1N1CCCC1 RROPNTBIMNIFQF-UHFFFAOYSA-N 0.000 claims 2
- CQIKWLIAOWUKBH-UHFFFAOYSA-N n-[(z)-(3-amino-5-pyrrolidin-1-ylpyrazol-4-ylidene)amino]quinolin-6-amine Chemical compound C=1C=C2N=CC=CC2=CC=1NN=C1C(N)=NN=C1N1CCCC1 CQIKWLIAOWUKBH-UHFFFAOYSA-N 0.000 claims 2
- HQTPRSWCMWUBDM-UHFFFAOYSA-N n-[4-[5-amino-4-(phenylhydrazinylidene)pyrazol-3-yl]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1C1=NN=C(N)C1=NNC1=CC=CC=C1 HQTPRSWCMWUBDM-UHFFFAOYSA-N 0.000 claims 2
- SGZXTTIEHZYPIR-UHFFFAOYSA-N n-[5-phenyl-4-(phenylhydrazinylidene)pyrazol-3-yl]pyridine-3-carboxamide Chemical compound C=1C=CN=CC=1C(=O)NC1=NN=C(C=2C=CC=CC=2)C1=NNC1=CC=CC=C1 SGZXTTIEHZYPIR-UHFFFAOYSA-N 0.000 claims 2
- GVANXOOXDGQXOG-UHFFFAOYSA-N n-[[(4z)-5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methyl]-4-fluorobenzenesulfonamide Chemical compound C=1C=CC(F)=CC=1NN=C1C(N)=NN=C1CNS(=O)(=O)C1=CC=C(F)C=C1 GVANXOOXDGQXOG-UHFFFAOYSA-N 0.000 claims 2
- SQVAOULMTNRVBX-UHFFFAOYSA-N n-[[3-amino-5-(1-methylpyrrol-2-yl)pyrazol-4-ylidene]amino]quinolin-6-amine Chemical compound CN1C=CC=C1C1=NN=C(N)C1=NNC1=CC=C(N=CC=C2)C2=C1 SQVAOULMTNRVBX-UHFFFAOYSA-N 0.000 claims 2
- SHKSUWHNCVAINX-UHFFFAOYSA-N n-[[3-amino-5-(2-phenylethyl)pyrazol-4-ylidene]amino]isoquinolin-5-amine Chemical compound C=1C=CC2=CN=CC=C2C=1NN=C1C(N)=NN=C1CCC1=CC=CC=C1 SHKSUWHNCVAINX-UHFFFAOYSA-N 0.000 claims 2
- UNOKNGULZZDZHS-UHFFFAOYSA-N n-[[3-amino-5-(aminomethyl)pyrazol-4-ylidene]amino]isoquinolin-5-amine Chemical compound NCC1=NN=C(N)C1=NNC1=CC=CC2=CN=CC=C12 UNOKNGULZZDZHS-UHFFFAOYSA-N 0.000 claims 2
- CQIWUZXNMIFJRR-UHFFFAOYSA-N n-[[5-amino-4-[(3,4-difluorophenyl)hydrazinylidene]pyrazol-3-yl]methyl]-2-chloro-6-methylpyridine-3-carboxamide Chemical compound ClC1=NC(C)=CC=C1C(=O)NCC1=NN=C(N)C1=NNC1=CC=C(F)C(F)=C1 CQIWUZXNMIFJRR-UHFFFAOYSA-N 0.000 claims 2
- RSCYVUDBKJQUDQ-UHFFFAOYSA-N n-[[5-amino-4-[(3,4-difluorophenyl)hydrazinylidene]pyrazol-3-yl]methyl]pyridine-3-carboxamide Chemical compound C=1C=C(F)C(F)=CC=1NN=C1C(N)=NN=C1CNC(=O)C1=CC=CN=C1 RSCYVUDBKJQUDQ-UHFFFAOYSA-N 0.000 claims 2
- QCCVYSKGXCVTMP-UHFFFAOYSA-N n-[[5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methyl]butane-1-sulfonamide Chemical compound CCCCS(=O)(=O)NCC1=NN=C(N)C1=NNC1=CC=CC(F)=C1 QCCVYSKGXCVTMP-UHFFFAOYSA-N 0.000 claims 2
- DLVJLOQCTLZYNI-UHFFFAOYSA-N n-[[5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methyl]methanesulfonamide Chemical compound CS(=O)(=O)NCC1=NN=C(N)C1=NNC1=CC=CC(F)=C1 DLVJLOQCTLZYNI-UHFFFAOYSA-N 0.000 claims 2
- YPDAOYWHFXXDIM-UHFFFAOYSA-N n-[[5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methyl]pyridine-3-carboxamide Chemical compound C=1C=CC(F)=CC=1NN=C1C(N)=NN=C1CNC(=O)C1=CC=CN=C1 YPDAOYWHFXXDIM-UHFFFAOYSA-N 0.000 claims 2
- NABZQMUIKNFAPR-UHFFFAOYSA-N n-[[5-amino-4-[(3-fluorophenyl)hydrazinylidene]pyrazol-3-yl]methyl]pyridine-4-carboxamide Chemical compound C=1C=CC(F)=CC=1NN=C1C(N)=NN=C1CNC(=O)C1=CC=NC=C1 NABZQMUIKNFAPR-UHFFFAOYSA-N 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 210000004881 tumor cell Anatomy 0.000 claims 2
- ZQFGRJWRSLZCSQ-ZSFNYQMMSA-N verteporfin Chemical compound C=1C([C@@]2([C@H](C(=O)OC)C(=CC=C22)C(=O)OC)C)=NC2=CC(C(=C2C=C)C)=NC2=CC(C(=C2CCC(O)=O)C)=NC2=CC2=NC=1C(C)=C2CCC(=O)OC ZQFGRJWRSLZCSQ-ZSFNYQMMSA-N 0.000 claims 2
- 229960003895 verteporfin Drugs 0.000 claims 2
- WLWREBGRDCXHJB-UHFFFAOYSA-N (4e)-5-(2-methylsulfanylpyridin-3-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound CSC1=NC=CC=C1C1=NN=C(N)C1=NNC1=CC=CC=C1 WLWREBGRDCXHJB-UHFFFAOYSA-N 0.000 claims 1
- LOCZNPYOXAQMLP-UHFFFAOYSA-N (4e)-5-(2-tert-butyl-5-methylfuran-3-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound O1C(C)=CC(C=2C(C(N)=NN=2)=NNC=2C=CC=CC=2)=C1C(C)(C)C LOCZNPYOXAQMLP-UHFFFAOYSA-N 0.000 claims 1
- COUMTWLLHZIMFT-UHFFFAOYSA-N (4e)-5-(3,5-dimethyl-1,2-oxazol-4-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound CC1=NOC(C)=C1C1=NN=C(N)C1=NNC1=CC=CC=C1 COUMTWLLHZIMFT-UHFFFAOYSA-N 0.000 claims 1
- JGZLQKANBXMVQX-UHFFFAOYSA-N (4z)-5-(4-methylpiperazin-1-yl)-4-(phenylhydrazinylidene)pyrazol-3-amine;dihydrochloride Chemical compound Cl.Cl.C1CN(C)CCN1C1=NN=C(N)C1=NNC1=CC=CC=C1 JGZLQKANBXMVQX-UHFFFAOYSA-N 0.000 claims 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims 1
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 claims 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 claims 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims 1
- VLDGPLKMTUJZMF-UHFFFAOYSA-N 4-(naphthalen-2-ylhydrazinylidene)pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(C=CC=C2)C2=C1 VLDGPLKMTUJZMF-UHFFFAOYSA-N 0.000 claims 1
- LPMZXOZBJJUFGG-UHFFFAOYSA-N 4-(pyridin-3-yldiazenyl)-1H-pyrazole-3,5-diamine Chemical compound NC1=NNC(N)=C1N=NC1=CC=CN=C1 LPMZXOZBJJUFGG-UHFFFAOYSA-N 0.000 claims 1
- RYBDYKTYLCTOPG-UHFFFAOYSA-N 4-[(2-chlorophenyl)diazenyl]-1H-pyrazole-3,5-diamine Chemical compound Nc1n[nH]c(N)c1N=Nc1ccccc1Cl RYBDYKTYLCTOPG-UHFFFAOYSA-N 0.000 claims 1
- PFILEHJRVJXGIF-UHFFFAOYSA-N 4-[(3-chlorophenyl)diazenyl]-1H-pyrazole-3,5-diamine Chemical compound Nc1n[nH]c(N)c1N=Nc1cccc(Cl)c1 PFILEHJRVJXGIF-UHFFFAOYSA-N 0.000 claims 1
- LKLZCFXKZBZDMZ-UHFFFAOYSA-N 4-[(3-fluorophenyl)diazenyl]-5-methyl-1H-pyrazol-3-amine Chemical compound CC1=NNC(N)=C1N=NC1=CC=CC(F)=C1 LKLZCFXKZBZDMZ-UHFFFAOYSA-N 0.000 claims 1
- MAXOECZSANDDDP-UHFFFAOYSA-N 4-[(3-methoxyphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound COC1=CC=CC(NN=C2C(=NN=C2N)N)=C1 MAXOECZSANDDDP-UHFFFAOYSA-N 0.000 claims 1
- RSBGVXCEYFJUAX-UHFFFAOYSA-N 4-[(4-bromophenyl)diazenyl]-1H-pyrazole-3,5-diamine Chemical compound Nc1n[nH]c(N)c1N=Nc1ccc(Br)cc1 RSBGVXCEYFJUAX-UHFFFAOYSA-N 0.000 claims 1
- JYRJFAVMZYKBID-UHFFFAOYSA-N 4-[(4-morpholin-4-ylphenyl)hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC=C(N2CCOCC2)C=C1 JYRJFAVMZYKBID-UHFFFAOYSA-N 0.000 claims 1
- ZMIQHAQOBHYLAA-UHFFFAOYSA-N 4-[[3-(morpholin-4-ylmethyl)-5-nitrophenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1=NNC1=CC(CN2CCOCC2)=CC([N+]([O-])=O)=C1 ZMIQHAQOBHYLAA-UHFFFAOYSA-N 0.000 claims 1
- BZKUNPLVLZNWBZ-UHFFFAOYSA-N 4-[[3-methoxy-5-(trifluoromethyl)phenyl]hydrazinylidene]pyrazole-3,5-diamine Chemical compound FC(F)(F)C1=CC(OC)=CC(NN=C2C(=NN=C2N)N)=C1 BZKUNPLVLZNWBZ-UHFFFAOYSA-N 0.000 claims 1
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims 1
- YJNGBKRYDSMTCH-UHFFFAOYSA-N 4h-pyrazole-3,5-diamine Chemical compound NC1=NN=C(N)C1 YJNGBKRYDSMTCH-UHFFFAOYSA-N 0.000 claims 1
- JISYBKQCYRYPOF-UHFFFAOYSA-N 5-methyl-4-(phenylhydrazinylidene)pyrazol-3-amine Chemical compound CC1=NN=C(N)C1=NNC1=CC=CC=C1 JISYBKQCYRYPOF-UHFFFAOYSA-N 0.000 claims 1
- 239000005541 ACE inhibitor Substances 0.000 claims 1
- 208000005590 Choroidal Neovascularization Diseases 0.000 claims 1
- 206010060823 Choroidal neovascularisation Diseases 0.000 claims 1
- KMFWMJHTZFAOFC-UHFFFAOYSA-N ClC=1C=C(C=CC1)NN=C1C(=NN=C1C)N.FC=1C=C(C=CC1)NN=C1C(NN=C1C)N Chemical compound ClC=1C=C(C=CC1)NN=C1C(=NN=C1C)N.FC=1C=C(C=CC1)NN=C1C(NN=C1C)N KMFWMJHTZFAOFC-UHFFFAOYSA-N 0.000 claims 1
- 206010055665 Corneal neovascularisation Diseases 0.000 claims 1
- 206010012442 Dermatitis contact Diseases 0.000 claims 1
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 1
- 206010065630 Iris neovascularisation Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- UHCBROSFOBQTLV-UHFFFAOYSA-N O1N=NC=C1NC1=NN=CC1=NNC1=CC=CC=C1 Chemical compound O1N=NC=C1NC1=NN=CC1=NNC1=CC=CC=C1 UHCBROSFOBQTLV-UHFFFAOYSA-N 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 208000007135 Retinal Neovascularization Diseases 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 208000002029 allergic contact dermatitis Diseases 0.000 claims 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000004709 cell invasion Effects 0.000 claims 1
- JDBSGKGTKLQVEM-UHFFFAOYSA-N chembl1518606 Chemical compound NC1=NN(C=2C=CC=CC=2)C(N)=C1N=NC1=CC=CC=C1 JDBSGKGTKLQVEM-UHFFFAOYSA-N 0.000 claims 1
- BHSCLHDQTNDXDV-UHFFFAOYSA-N chembl1589011 Chemical compound CC1=CC=CC=C1N=NC1=C(N)NN=C1N BHSCLHDQTNDXDV-UHFFFAOYSA-N 0.000 claims 1
- KNSDLOIIFWEGLS-UHFFFAOYSA-N chembl217734 Chemical compound NC1=NNC(N)=C1N=NC1=CC=CC([N+]([O-])=O)=C1 KNSDLOIIFWEGLS-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 208000010247 contact dermatitis Diseases 0.000 claims 1
- 201000000159 corneal neovascularization Diseases 0.000 claims 1
- 230000003511 endothelial effect Effects 0.000 claims 1
- 230000012010 growth Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 201000001268 lymphoproliferative syndrome Diseases 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- FZVGNSBERUDGMW-UHFFFAOYSA-N n-[[3-amino-5-(2-fluorophenyl)pyrazol-4-ylidene]amino]phthalazin-5-amine Chemical compound C=1C=CC2=CN=NC=C2C=1NN=C1C(N)=NN=C1C1=CC=CC=C1F FZVGNSBERUDGMW-UHFFFAOYSA-N 0.000 claims 1
- 210000000440 neutrophil Anatomy 0.000 claims 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims 1
- 229940124531 pharmaceutical excipient Drugs 0.000 claims 1
- 230000002165 photosensitisation Effects 0.000 claims 1
- 239000003504 photosensitizing agent Substances 0.000 claims 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims 1
- 230000002207 retinal effect Effects 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000004614 tumor growth Effects 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 0 CN=NC1C(*)N(*)N(*)C1* Chemical compound CN=NC1C(*)N(*)N(*)C1* 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 125000005842 heteroatom Chemical group 0.000 description 3
- 125000000928 benzodioxinyl group Chemical group O1C(=COC2=C1C=CC=C2)* 0.000 description 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 2
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 2
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 2
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 2
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 2
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000006088 2-oxoazepinyl group Chemical group 0.000 description 1
- 125000004638 2-oxopiperazinyl group Chemical group O=C1N(CCNC1)* 0.000 description 1
- 125000004637 2-oxopiperidinyl group Chemical group O=C1N(CCCC1)* 0.000 description 1
- 125000005986 4-piperidonyl group Chemical group 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000002785 azepinyl group Chemical group 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000005507 decahydroisoquinolyl group Chemical group 0.000 description 1
- 125000005879 dioxolanyl group Chemical group 0.000 description 1
- 125000003844 furanonyl group Chemical group 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000004628 isothiazolidinyl group Chemical group S1N(CCC1)* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000003965 isoxazolidinyl group Chemical group 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000005060 octahydroindolyl group Chemical group N1(CCC2CCCCC12)* 0.000 description 1
- 125000005061 octahydroisoindolyl group Chemical group C1(NCC2CCCCC12)* 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 125000005476 oxopyrrolidinyl group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 125000006090 thiamorpholinyl sulfone group Chemical group 0.000 description 1
- 125000006089 thiamorpholinyl sulfoxide group Chemical group 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33526501P | 2001-11-30 | 2001-11-30 | |
| US10/077,238 US7105503B2 (en) | 2000-04-07 | 2002-02-15 | Pyrazole compounds |
| PCT/CA2002/001583 WO2003045379A1 (en) | 2001-11-30 | 2002-10-18 | Hydrazonopyrazole derivatives and their use as therapeutics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005519878A JP2005519878A (ja) | 2005-07-07 |
| JP2005519878A5 true JP2005519878A5 (https=) | 2010-09-30 |
Family
ID=26759053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003546881A Ceased JP2005519878A (ja) | 2001-11-30 | 2002-10-18 | ヒドラゾノピラゾール誘導体および治療剤としてのその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US7875728B2 (https=) |
| EP (1) | EP1450791A1 (https=) |
| JP (1) | JP2005519878A (https=) |
| CN (1) | CN1671379A (https=) |
| AU (2) | AU2002333114B2 (https=) |
| CA (1) | CA2468562C (https=) |
| MX (1) | MXPA04005204A (https=) |
| RU (1) | RU2332996C2 (https=) |
| WO (1) | WO2003045379A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CY2010012I2 (el) | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
| RU2332996C2 (ru) | 2001-11-30 | 2008-09-10 | КьюЭлТи Инк. | Производные гидразонпиразола и их применение в качестве лекарственного средства |
| TWI280128B (en) | 2002-05-22 | 2007-05-01 | Smithkline Beecham Corp | 3'-[(2Z)-[1-(3,4- dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| TW200526638A (en) | 2003-10-22 | 2005-08-16 | Smithkline Beecham Corp | 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
| GB0419416D0 (en) * | 2004-09-01 | 2004-10-06 | Inst Of Ex Botany Ascr | 4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof |
| ECSP077628A (es) | 2007-05-03 | 2008-12-30 | Smithkline Beechman Corp | Nueva composición farmacéutica |
| GB0908614D0 (en) | 2009-05-19 | 2009-06-24 | Tayside Flow Technologies Ltd | A vascular graft |
| MX2011012668A (es) | 2009-05-29 | 2011-12-16 | Glaxosmithkline Llc | Metodos de administracion de compuestos agonistas de trombopoyetina. |
| RU2546005C2 (ru) | 2009-09-15 | 2015-04-10 | Кью Эл Ти ИНК. | Фармацевтические составы, содержащие 9-цис-ретиниловые сложные эфиры в липидном наполнителе |
| US9173856B2 (en) | 2010-04-19 | 2015-11-03 | Qlt Inc. | Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency |
| CA2865935C (en) | 2012-03-01 | 2021-12-14 | Qlt Inc. | Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency |
| CN104958288B (zh) * | 2015-06-26 | 2017-08-11 | 苏州大学 | 一种血小板抑制剂及其在制备抗血小板疾病药物中的应用 |
| KR102128509B1 (ko) * | 2018-12-19 | 2020-07-01 | 한국과학기술연구원 | 말단 아민기에 아릴 또는 헤테로아릴기가 치환된 신규한 히드라존 유도체 및 이의 용도 |
| KR102356644B1 (ko) * | 2020-06-19 | 2022-01-28 | 한국과학기술연구원 | 신규한 옥소피리다지닐-페닐-카르보노하이드라조노일 디시아나이드 화합물 및 이의 용도 |
| EP4169916A4 (en) * | 2020-06-19 | 2024-07-10 | Korea Institute of Science and Technology | CARBONOHYDRAZONOYL DICYANIDE COMPOUND COMPRISING AT LEAST TWO TYPES OF ARYL OR HETEROARYL LINKED BY A NOVEL LINKER, AND USE THEREOF |
| KR102633087B1 (ko) * | 2020-06-19 | 2024-02-05 | 한국과학기술연구원 | 신규한 융합헤테로고리-카르보노하이드라조노일 디시아나이드 화합물 및 이의 용도 |
| CN113583110B (zh) * | 2021-08-19 | 2023-07-21 | 华南农业大学 | 一种苯并三唑半抗原、人工抗原和抗体及其制备方法与应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH373842A (de) * | 1959-09-11 | 1963-12-15 | Geigy Ag J R | Verfahren zur Herstellung von in Wasser dispergierbaren, schwer löslichen Azofarbstoffen |
| NL127251C (https=) * | 1965-01-15 | |||
| DE2248738A1 (de) * | 1972-10-05 | 1974-04-11 | Bayer Ag | Kationische diazacyaninfarbstoffe |
| SU1162799A1 (ru) * | 1982-07-09 | 1985-06-23 | Витебский государственный медицинский институт | Способ получени 4-арилгидразонов пиразолидинтриона-3,4,5 |
| US4562248A (en) * | 1983-11-25 | 1985-12-31 | Eastman Kodak Company | Azo dyes from unsubstituted or substituted 3-amino-pyridine and aryl or heterocyclic couplers |
| CA2369076A1 (en) | 2000-02-05 | 2001-08-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compositions useful as inhibitors of erk |
| HUP0202332A2 (en) | 2000-02-05 | 2002-10-28 | Vertex Pharma | Pyrazole compositions useful as inhibitors of erk |
| WO2001056557A2 (en) | 2000-02-05 | 2001-08-09 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of erk |
| US6436915B1 (en) * | 2000-04-07 | 2002-08-20 | Kinetek Pharmaceuticals, Inc. | Pyrazole compounds |
| US6214813B1 (en) * | 2000-04-07 | 2001-04-10 | Kinetek Pharmaceuticals, Inc. | Pyrazole compounds |
| GB0102687D0 (en) | 2001-02-02 | 2001-03-21 | Pharmacia & Upjohn Spa | Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them |
| RU2332996C2 (ru) | 2001-11-30 | 2008-09-10 | КьюЭлТи Инк. | Производные гидразонпиразола и их применение в качестве лекарственного средства |
| EP1456180B1 (en) | 2001-12-21 | 2007-10-03 | Vernalis (Cambridge) Limited | 3-(2,4)dihydroxyphenyl-4-phenylpyrazoles and their medical use |
-
2002
- 2002-10-18 RU RU2004119957/04A patent/RU2332996C2/ru not_active IP Right Cessation
- 2002-10-18 JP JP2003546881A patent/JP2005519878A/ja not_active Ceased
- 2002-10-18 CA CA2468562A patent/CA2468562C/en not_active Expired - Fee Related
- 2002-10-18 WO PCT/CA2002/001583 patent/WO2003045379A1/en not_active Ceased
- 2002-10-18 US US10/497,046 patent/US7875728B2/en not_active Expired - Fee Related
- 2002-10-18 MX MXPA04005204A patent/MXPA04005204A/es unknown
- 2002-10-18 EP EP02803715A patent/EP1450791A1/en not_active Withdrawn
- 2002-10-18 AU AU2002333114A patent/AU2002333114B2/en not_active Ceased
- 2002-10-18 CN CNA02827752XA patent/CN1671379A/zh active Pending
-
2008
- 2008-12-04 AU AU2008252075A patent/AU2008252075A1/en not_active Abandoned
-
2010
- 2010-12-23 US US12/977,794 patent/US8445694B2/en not_active Expired - Fee Related
-
2013
- 2013-04-29 US US13/872,819 patent/US20140107125A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005519878A5 (https=) | ||
| RU2332996C2 (ru) | Производные гидразонпиразола и их применение в качестве лекарственного средства | |
| RU2492167C2 (ru) | Производные аминотриазола в качестве агонистов alх | |
| RU2317291C2 (ru) | Производные пиримидина в качестве модуляторов рецептора инсулинподобного фактора роста 1 (igf-1), фармацевтическая композиция, способы получения (варианты) и применение | |
| AU734275C (en) | Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors | |
| ES2536191T3 (es) | Derivados de sulfonamida | |
| RU2426731C2 (ru) | Производные арил-изоксазоло-4-ил-оксадиазола | |
| JP2006505512A5 (https=) | ||
| JP2006503081A5 (https=) | ||
| ZA200305619B (en) | Substituted triazole diamine derivatives as kinase inhibitors. | |
| CA2396824A1 (en) | Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 | |
| TWI659950B (zh) | 作為硝醯基予體之吡唑啉酮衍生物 | |
| CA2466490A1 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| RU2006127575A (ru) | Соединение триазола и их применение в качестве антагонистов метаботропного рецептора глутамата | |
| KR19990063874A (ko) | 항염증제로서 수의학적 치료에 사용하기 위한 치환 피라졸릴 벤젠술폰아미드 | |
| RU2013155456A (ru) | Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka | |
| WO2004045509A2 (en) | Method of using a cox-2 inhibitor and a 5-ht1a receptor modulator as a combination therapy | |
| RU96100763A (ru) | Фенильные гетероциклы как ингибиторы циклооксигеназы-2 | |
| CA2440238A1 (en) | Novel amines as histamine-3 receptor ligands and their therapeutic applications | |
| JP2007516173A5 (https=) | ||
| JP2008044952A (ja) | 高コンダクタンス型カルシウム感受性kチャネル開口薬 | |
| RU96115039A (ru) | Пиразолилзамещенные бензолсульфонамиды для лечения воспалений | |
| EP2906553A1 (en) | Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero)aryl)-pyrrolidin-1-yl]-methanone derivatives | |
| US20040138261A1 (en) | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation | |
| RU2011116232A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы |